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ABSTRACT 
DOUGLAS TSAO: Identifying Molecular Mechanisms of Catechol O-Methyltransferase 
Activity and Regulation 
 
 
 Catechol O-methyltransferase (COMT) is a regioselective enzyme that functions by 
metabolizing catecholamines such as neurotransmitters and hormones via methylation at a single 
hydroxyl of the catechol moiety.  Two cofactors are necessary in order to catalyze the reaction: 
S-adenosyl-L-methionine (SAM) and a divalent metal cation. Through computational docking 
studies, we show that a reason metal cations may be necessary for catalysis is due to its role in 
aligning the donating methyl group of SAM with the nucleophile of the substrate. 
 It is intriguing that an enzyme whose sole function is to degrade catecholamines contains 
highly conserved residues responsible for regioselective behavior at the catechol moiety, a 
function in which site-specific chemistry seems unnecessary.  Our barrier height calculations for 
two different COMT ligands suggest that deprotonating the meta-hydroxyl leads to higher rates 
of methylation and consequently there is evolutionary pressure for selecting residues that can 
dock the ligand in an ideal conformation for efficient catalysis. 
 Our group previously identified three major haplotypes of COMT, where two single 
nucleotide polymorphisms (SNPs) produce synonymous changes and an additional SNP that 
creates a low enzymatic activity variant (Val108Met).  Here we show that the allelic variant 
encoding for the low activity protein shows the highest translational efficiency among the 
haplotypes, suggesting evolutionary selection of an RNA-structure destabilizing allele to 
compensate for the low activity mutation present within its protein structure.  We provide a 
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mechanism whereby destabilizing alleles may facilitate translation initiation via computational 
modeling of each mRNA haplotype. 
 One of several biological factors that COMT influences is pain perception because of its 
role in degrading the neurotransmitters.  Peripherally injected serotonin has been clinically 
shown to induce a hyperalgesic effect.  Here we report that serotonin-induced hyperalgesia may 
be induced by inhibition of COMT.  Our kinetic assays reveal serotonin as a non-competitive 
inhibitor with respect to catechol substrates.  From computational modeling, we observe 
serotonin actively competing with the methyl donor S-adenosyl-L-methionine at the active site.  
Binding of COMT to serotonin inhibits the methyl donor from entering the active site, thus 
preventing methylation of COMT substrates.  
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CHAPTER I: GENETIC AND STRUCTURAL FEATURES OF CATECHOL O-
METHYLTRANSFERASE 
 
Structural Characterization of Catechol O-Methyltransferase  
 Catechol O-methyltransferase (COMT) is an enzyme found in virtually all mammalian 
tissues and is responsible for metabolizing catechols (either endogenous or exogenous in origin) 
by methylating a single hydroxyl group at either the meta- or para- position (1).  Two additional 
cofactors are required for the reaction to occur: S-adenosyl-L-methionine (SAM) and a divalent 
metal cation.  Magnesium serves as the metal catalyst within the cell, although in vitro studies 
have shown that other metals are sufficient for activity (2).  Methylation of catechols proceeds 
via a SN2 mechanism, where the catechol is first deprotonated at a single hydroxyl and the 
resultant oxyanion attacks the cationic methyl group thereby displacing it from the SAM cofactor 
(3).   
  There are two main isoforms of COMT: a soluble (S-COMT) and membrane-bound 
(MB-COMT) isoform (1).  The predominant isoform within the human body is S-COMT.  The 
MB-COMT isoform is mostly present at the human brain, and is bound to the membrane of the 
endoplasmic reticulum as opposed to the cellular membrane (4,5).  With the exception of the first 
50 residues, the two sequences remain identical since they derive from the same gene.  Two 
distinct promoters are responsible for the isoforms, where transcribing the first promoter at the 
third exon results in the MB-COMT isoform, while the distal promoter for S-COMT is 
approximately 200 nucleotides downstream on the third exon (6).  From secondary structure 
predictions, it is believed that the first 50 residues of MB-COMT form a transmembrane α-helix 
(7).   
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 The crystal structure of S-COMT (and henceforth COMT) was originally solved in 1994 
for rats (PDB: 1VID) (8), with a human isoform eventually solved in 2008 (PDB: 3BWM) (9).  
The topology of COMT resembles a Rossman fold, with a 7-stranded mostly parallel β-sheet 
sandwiched between 5 α-helices at the N-terminal side and 3 α-helices at the opposing side 
(Figure 1.1A).  For COMT, the Rossman fold topology is used for recognition and binding of the 
nucleotide cofactor SAM.  Apo-COMT initially binds to SAM, as its binding site is recessed 
deepest inside the active site.   
 Adjacent to the SAM binding site is a group of negatively charged residues (D141, D169, 
E199) and the carbonyl of N170 that coordinate to magnesium (Figure 1.1B).  The exact 
coordination of Mg2+ within the active site is a topic of debate in the field (10,11).  From the 
crystal structure, two coordination sites are occupied by each hydroxyl from the catechol.  
However, an inhibitor is used to prevent methylation of the substrate for all crystal structures of 
COMT.  These inhibitors act to prevent methylation by reducing the nucleophilicity of the 
oxyanion that attacks the methyl group of SAM.  For many of the inhibitors (including those 
used for crystallography), nitrates are added to the catechol ring for this purpose.  These nitrate 
groups reduce the nucleophilicity due to the number of resonance structures formed once a 
hydroxyl is deprotonated.  Therefore, it is thought that the catechol coordinates twice to 
magnesium because the nucleophilicity of the catechol is dampened.  Several groups have 
demonstrated that molecular dynamics (MD) simulations of a natural catechol substrate with 
COMT result in a complex where magnesium is mono-coordinated with the catechol (10,11).  
The exact hydroxyl that is coordinated with magnesium is a further topic of debate, where one 
group obtains a complex with the oxyanion coordinated to magnesium (11) and another group 
obtains a complex with the neighboring hydroxyl group coordinated to magnesium (10).  
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Nonetheless, Mg2+ remains hexacoordinated next to the sulfonium center of SAM where the last 
coordination site is occupied by water. 
 The catechol substrate is the third and final ligand bound to COMT prior to methylation 
(12).  Its binding site is therefore the most solvent accessible of the three ligands (9).  The  β-turn 
separating anti-parallel strands 6 and 7 form a loop that recognizes catechol substrates.  Residue 
L198 within this catechol-binding loop make direct contact with the catechol ring itself.  Further 
along the loop, residues R201 and E202 form the outer pocket.  A loop that connects β-strand 6 
and α-helix 8 contains a proline residue at position 174 that stacks with the catechol ring in an 
edge-to-face interaction.   
 A region of the protein known as the “hydrophobic wall” consists of residues that bind to 
the side-chain of a catechol substrate (8).  Residues E199 and Y200 of the catechol-binding loop 
have been found in MD simulations to migrate toward the catechol side-chain (11). Two 
additional residues outside the two aforementioned loop domains form van der Waals (vdW) 
contacts with the catechol: M40 and W38, located on the loop between α-helices 2 and 3.  
Tryptophan 143, residing at the tail end of α-helix 7, has been shown via MD simulations to bind 
the side-chain of catechols, potentially via a cation-π interaction (11).  These residues of the 
hydrophobic wall are important not only for binding to the substrate, but they are responsible for 
the regioselective properties of the enzyme (11).  Specifically, interactions of the side-chain with 
residues of the hydrophobic wall guide the substrate into the active site.  Therefore, the catechol 
is oriented into the active site in such a way that the side-chain interactions are most favorable.  
For many biological ligands, the side-chain of catechol substrates are closer to the 3’OH.  
Consequently, many COMT products are methylated at the meta-position. 
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 A common variant of COMT has a mutation at position 108 (158 for MB-COMT) where 
valine is substituted for methionine (1,13,14).  Interestingly, this residue is located over 15 Å 
away from the active site and is exposed on the solvent-accessible surface of the protein (9).  Yet 
it has been shown from several studies that the 108Met variant displays lower enzymatic activity 
within the cell (1,12,15).  The protein destabilization resulting from the substitution varies in 
species; there is approximately a 4 kcal/mol destabilization for rats, and only a 1 kcal/mol 
destabilization for humans (16).  Furthermore, a comparison of the crystal structures between 
108Val and 108Met reveals a root mean square deviation (RMSD) of only 0.2 Å (9).  However, 
MD simulations performed for each variant reveal some differences in their dynamics (16).  The 
108Met variant exposes more residues to the solvent, thereby potentially facilitating its 
degradation through easier access to proteases.   
 
Three Main Haplotypes of COMT 
 The Val108Met polymorphism is not the exclusive variant known for COMT.  Overall, 
there are three known haplotypes that were shown to have functional effects and encompass 96% 
of the human population.  These haplotypes were first discovered in a pain-association study, and 
therefore are named according to their originally associated phenotypes (Figure 1.2A): low pain 
sensitivity (LPS), average pain sensitivity (APS), and high pain sensitivity (HPS) (13).  The most 
common in Caucasian population is APS haplotype that encodes for the 108Met variant that has 
lower enzymatic activity.  The next frequent haplotype is LPS, which corresponds to the wild-
type COMT protein. HPS exhibits the lowest activity of the three haplotypes; however, there is 
no difference in the protein structure compared to the wild type.  Only a single synonymous 
mutation (rs4818) differentiates LPS and HPS within the coding region of the gene. 
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 The low enzymatic activity displayed by HPS haplotypes is a direct result of its low 
protein abundance (Figure 1.2C,D) (15).  Secondary structural predictions of the mRNA 
transcript suggest a highly stable stem-loop structure formed exclusively by the HPS haplotype 
(Figure 1.2B) (15).  These predictions were confirmed through further mutagenesis studies where 
point mutations were made along the LPS transcript to induce the HPS stem-loop structure, and 
rescue mutations were performed for the HPS haplotype to recapitulate the LPS stem-loop 
structure.  Mutants that were predicted to have the HPS stem structure showed low protein 
expression, while the rescue mutants that were predicted to have the LPS stem structure 
displayed higher protein expression.  Therefore, it was concluded that HPS haplotypes exhibit 
low protein abundance in the cell due to a highly stable stem-loop on its mRNA transcript.  A 
stem-loop that possesses a melting temperature (Tm) higher than 70 °C can inhibit its translation 
due to the high-energy requirements needed for the ribosome to unwind this region.   
 
Biological Significance of COMT Haplotypes 
 Those with the wild-type COMT haplotype experience the least amount of pain 
sensitivity due to the enzyme’s higher activity (13,15).  Neurotransmitters such as dopamine, 
epinephrine, and norepineprine are endogenous substrates of COMT due to their catecholamine 
structure (14).  Sustained levels of catecholamines are known to induce a pain response by 
binding to a class of G-protein coupled receptors known as β-adrenergic receptors.  Specifically, 
it has been shown that β2- and β3-receptors are responsible for the low COMT activity dependent 
enhanced pain sensitivity (17).  β-adrenergic receptors are activated by catecholamines and 
initiate the signaling cascade by stimulating cAMP production.  When methylated by COMT, 
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catecholamines lose their biological activity, and β2- and β3-receptors activities decrease.  The 
decrease in β2 and β3 receptor activity is associated with a lower perception of pain. 
 The three haplotypes of COMT have been associated chronic pain phenotypes including 
temporomandibular joint disorder and fibromyalgia (13,18).  Furthermore, the probability of 
post-operative pain increases when patients possess alleles for lower COMT activity (19). 
However, other factors are associated with COMT including the development of white brain 
matter and drug response (20,21).  For instance, a common treatment for the symptoms of 
Parkinson’s disease is the prescription of levodopa.  Levodopa contains a catecholamine 
structure that undergoes methylation by COMT.  Treatment of patients with COMT haplotypes 
that have a higher enzymatic activity is less effective unless a COMT inhibitor is co-
administered. 
 
Summary 
 Studying structural, molecular, and genetic mechanisms of COMT activity and regulation 
are thus important elements of understanding human pain perception and its variability within 
the human population.  Moreover, the biological significance of COMT spans beyond pain 
perception due to the fundamental role that COMT plays in degrading both endogenous and 
exogenous catechols, thereby making it critical for many other phenotypes including blood 
pressure, moods and drug dependence.  Effective diagnosis and treatments of individuals will 
improve as our understanding of COMT advances.  
In the next two chapters, we further explore the structural details of COMT activity.  The 
mechanism of how SAM is initially accommodated within the COMT active site is discussed, 
followed by a detailed study of the regioselectivity of COMT.   Next, we examine how COMT is 
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regulated at the mRNA level and in the presence of serotonin in chapters 4 and 5, respectively.  
Our work on COMT regioselectivity and mRNA regulation have been recently published 
(22,23), while the manuscripts for SAM binding and serotonin regulation are currently under 
preparation. 
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Figure 1.1. Structural features of S-COMT.  (A) Overall topology of S-COMT as represented in 
cartoon format.  Protein is colored from blue (N-terminus) to red (C-terminus).  3,5-
dinitrocatechol is colored green, Mg2+ is colored orange, and SAM is colored gray.  (B) 
Magnesium coordination within COMT active site (as depicted from the crystal structure).  
Coordination bonds are represented by dashed yellow lines.  (C) Interactions between 3,5-
dinitrocatechol and COMT residues.  3,5-dinitrocatechol is shown as red.  Blue residues define 
the inner pocket, green residues define the outer lip, and purple residues are classified as the 
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“gatekeeper” residues, as defined by Rutherford et al (9).  (D) Surface representation of 3,5-
dinitrocatechol bound to COMT.  The “hydrophobic wall” residues are highlighted in red. 
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Figure 1.2. Haplotypes of COMT.  From “Human catechol-O-methyltransferase haplotypes 
modulate protein expression by altering mRNA secondary structure. Science, 314, 1930-1933”.  
Reprinted with permission from AAAS.  (A) Diagram of MB-COMT and S-COMT gene with 
common SNP locations for each haplotype.  Frequencies were derived from a cohort study of 
202 healthy Caucasian females.  Large rectangles along the gene represent exon regions while 
the smaller regions are intronic.  SNPs are highlighted by a vertical black line.  (B) Predicted 
stem-loop structure for COMT haplotypes.  Location of SNPs are highlighted with the 
corresponding arrows.  (C) Enzymatic activity of each haplotype within a PC-12 (rat 
pheochromacytoma) cell lysate.  (D) Expression levels of each haplotype within PC-12 cells. 
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ABSTRACT 
 Methyltransferases possess a homologous domain that requires both a divalent 
metal cation and S-adenosyl-L-methionine (SAM) to catalyze its reactions.   The kinetics of 
several methyltransferases has been well characterized; however, the details regarding 
their structural mechanisms have remained unclear to date.  Using catechol O-
methyltransferase as a model, we perform computational docking simulations to elucidate 
the initial stages of cofactor binding.  We find that SAM adopts a different docking pose in 
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the absence of metal and substrate in comparison to the holoenzyme, illustrating that the 
metal reorients SAM in a conformation suitable for donating its methyl substituent to the 
recipient ligand. 
  
 
INTRODUCTION 
 Catechol O-methyltransferase (COMT) is a metalloenzyme that metabolizes biologically 
active catechol-containing structures by methylation of a single hydroxyl group (1).  A number 
of neurotransmitters contain a catecholamine moiety and are deactivated by COMT.  Activity of 
COMT is thus correlated with many critical biological functions including cognition (24), stress 
response (25), and pain sensitivity (13).   
 Crystallographic and enzymatic studies of COMT have given significant insight to its 
mode of activity (9,12). The cofactor S-adenosyl-L-methionine (SAM), responsible for donating 
the methyl group to the catechol, initially binds to the enzyme.  This complex then binds a 
divalent metal cation through coordination bonds to several acidic residues and a single water 
molecule in the active site.  Additional residues then bind to the catechol substrate, and the metal 
coordinates to the hydroxyl group inside the active site. Although the general kinetic mechanism 
for COMT substrate binding is known, the structural details that govern binding have yet to be 
identified.  Current crystal structures of COMT are bound to SAM, Mg2+, and an inhibitor.  
Using computational docking tools (Methods; (26,27)), we dock SAM to an apo-COMT protein 
to determine the initial binding poses.  We also perform docking simulations with SAM inside a 
COMT•metal•catechol complex (holo-COMT) and compare to the crystal structure.  From our 
results, we show that the metal cation is critical for aligning SAM in a conformation suitable for 
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catalysis with the substrate.  Here we detail a mechanism whereby SAM initially binds to 
COMT, and upon metal binding, subsequently reorients itself for the enzyme to accommodate 
the substrate and facilitate methyl transfer.   
 
METHODS 
 We employ the MedusaDock package to generate possible ligand conformations within 
the protein active site, and utilize the MedusaScore package to evaluate each conformation 
generated by MedusaDock (26,27). MedusaDock enables flexible docking of both the ligand and 
the side-chain amino acids of the protein.  We perform all ligand docking simulations using the 
crystal structure of human COMT (PDB: 3BWM) (9).    
 Prior to docking S-adenosyl methionine (SAM) to apo-COMT, we stripped all 
crystallized ligands bound to COMT.  Crystallographic waters that were in the active site were 
retained for our docking simulations.   We performed 200 docking simulations, where each 
simulation began with a different seed number and each conformation generated from a 
simulation was subsequently minimized.  All conformations were then ranked according to their 
free energy value.  The lowest energy structure is determined to be the native pose.   
  To model the entire complex with SAM, Mg2+, and catechol bound (holo-COMT), we 
add several constraints and make several modifications.  First, we replace Mg2+ with Zn2+ since 
there are no Mg2+ parameters previously defined in the MedusaScore force field.  However, 
previous experiments suggest that Zn2+ is a suitable alternative for Mg2+ as it is ~80% as 
effective (2). The general mechanism is that the metal divalent ion displaces the monovalent 
cationic amine group and acts as a steric block for the rest of the methionine side-chain.  We 
place constraints to fix the position of the metal and catechol as found in the crystal structure, 
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while we flexibly dock SAM into the active site.   We find that the lowest energy pose 
recapitulates the crystal structure, with a heavy atom root mean square deviation of 0.68 Å.   
 
RESULTS AND DISCUSSION 
 In the absence of metal and substrate, portions of SAM bind to a different groove of 
COMT (Figure 2.1A).  The adenosine moiety of SAM remains identical to the holo-COMT 
structure, with the Ile91 side-chain packing on top of the pyrimidine portion of adenine and the 
imidazole of His142 participating in a perpendicular edge-to-face aromatic interaction with the 
pyrimidine (Figure 2.1B).  The imidazole of adenine participates in an additional edge-to-face 
interaction with the indole side-chain of Trp143.  Additional polar contacts are made between 
residues 118-120 and the purine nitrogens.  The two hydroxyl groups of the ribose participate in 
hydrogen bonding interactions with the side-chain of Glu90.   
 Similarities between the structures of SAM docked inside apo-COMT and holo-COMT 
end at the sulfonium center.  In the apo-COMT complex, the terminal amine group of SAM is 
involved in a hydrogen-bonding network with the side-chains of Asp141 and Asn170 and the 
backbone carbonyl of Met40 (Figure 2.1C).  The terminal carboxyl group participates in 
hydrogen bonding with Lys144 and a single water molecule.  The interactions highlighted here 
with methionine underlie an important point for why catalysis cannot occur without a metal.  
Lys144 is responsible for deprotonating the catechol to create the oxyanion responsible for 
attacking the methyl group.  In this particular pose, the Lys144 is preoccupied in a hydrogen-
bonding network and is unavailable to deprotonate. 
 Prior to catechol binding, a divalent metal cation must first displace the positively 
charged amine group.  Several divalent cations are capable of contributing to enzymatic activity, 
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although the native metal is magnesium in vivo (2).  Here we have modeled the divalent metal 
cation using Zn2+, which is 80% as effective as magnesium.  We find that upon metal binding, 
steric occlusion prevents the methionine of SAM from binding to the negatively charged pocket 
and is forced into an interior groove.  The amine group of the methionine maintains a hydrogen 
bond with Asp141, albeit at a different position, but additionally forms hydrogen bonds with the 
backbone carbonyl of Gly66 and the side-chain of Ser72.  The amide backbones of Ser72, Val42, 
and an additional water molecule form hydrogen bonds with the carboxyl group of SAM.  
Additional hydrophobic interactions are formed between the methionine side-chain and residues 
40, 42, 60, 68, and 89 inside this pocket (Figure 2.1D).   
 The results found here are initially surprising because it is expected that SAM binds to 
apo-COMT as found in the crystal structure of the holoenzyme complex.  The amine and 
carboxyl tail of SAM form favourable van der Waals contacts and satisfy their hydrogen bonds 
in both conformations.  However, the carboxylate side-chains within the active site preferentially 
bind to the amine side-chain of SAM, as the polar contacts are stronger than those shared with 
the backbone carbonyl groups of holo-COMT. 
 The role that magnesium plays in COMT activity has remained unclear to date.  Here we 
show that a divalent metal cation is essential for structural rearrangements of the SAM cofactor.  
Without any metal bound to COMT, methylation is 6.2% as effective as compared to with all 
cofactors present (2). The orientation of the methionine without metal present positions the 
donating methyl group 6.1 Å away from the oxyanion, compared to a separation of 2.7 Å in the 
presence of metal (Figure 2.1E).  Furthermore, the oxyanion and sulfonium no longer form a 
180° angle in between the methyl group.  This angle decreases to ~45° in the absence of metal.  
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Therefore binding to SAM and substrate alone produces no methylated product in the active site 
of COMT. 
 The mechanism described here is of broad biological interest since SAM serves as a 
common methyl donor for many methylation reactions, including CpG methylation (28). The 
binding site of SAM on COMT is homologous with many SAM-dependent methyltransferase 
structures, with several unique residues that form part of the catechol-binding site.  Thus our 
mechanism could be applicable to a broad range of methyltransferases that require a divalent 
metal cation and SAM. 
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FIG. 2.1. Binding configurations of SAM with and without metal.  (A) Alignment of SAM poses 
with and without metal.  Cyan structure represents without metal (apo-COMT) and gray structure 
represents SAM in the presence of metal.  In the right panel, the yellow structure is 
dinitrocatechol and green sphere is Zn2+.  Surface of protein is shown as an electrostatic map 
with blue regions representing clusters of positive charge and red representing regions of 
negative charge.  (B) Contacts made with adenosine portion of SAM (identical for apo- and holo-
COMT).  Cyan structure is adenosine and green structures are corresponding residues.  Yellow 
dashed lines indicate contacts.  (C) Contacts made with methionine portion of SAM (apo-
COMT).  Cyan structure is methionine portion of SAM.  (D) Contacts made with methionine 
portion of SAM (holo-COMT).  (E) Comparison of angle between methyl donor and accepting 
hydroxyl in the presence and absence of metal.  Cyan structure is apo-COMT and gray structure 
is holo-COMT. 
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Abstract 
 
 Catechol O-methyltransferase (COMT) metabolizes catechol moieties by methylating a 
single hydroxyl group at the meta- or para- hydroxyl position.  Hydrophobic amino acids near 
the active site of COMT influence the regioselectivity of this reaction.  Our sequence analysis 
highlights their importance by showing that these residues are highly conserved throughout 
evolution.  Reaction barriers calculated in the gas phase reveal a lower barrier during 
methylation at the meta- position, suggesting that the observed meta-regioselectivity of COMT 
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can be attributed to the substrate itself, and that COMT has evolved residues to orient the 
substrate in a manner that increases the rate of catalysis. 
 
 
1. Introduction 
 
 Catechol O-methyltransferase (COMT) is an enzyme that is primarily responsible for the 
deactivation of biologically active and toxic catechols and is found in virtually all mammalian 
tissues (1).  Many neurotransmitters and hormones within the body are characterized by a 
catechol or catecholamine structure and hence serve as substrates for COMT.  Deactivation of 
substrates proceeds by methylation of a single hydroxyl to form the meta- or para- product (29).    
 The active site consists of the catechol ligand, which is mono-coordinated to Mg2+, and 
the co-enzyme S-adenosyl methionine (SAM) that serves as the methyl donor.  Conversion to the 
guaiacol product proceeds via an SN2 mechanism, where Lys144 serves as a catalytic base and 
deprotonates a single hydroxyl to form the oxyanion that attacks a methyl group from the 
sulfonium.  Several groups have calculated the reaction barrier for catechol to be approximately 
20 kcal/mol in height (10,11,30).   
 Meta-methylation is the preferential product of COMT with the extent of regioselectivity 
dependent upon the catechol side-chain (Table 3.1) (12).  There has been no reported ligand 
where para-methylation is favored.  It has been largely believed that the preference for meta-
methylation stems from side-chain interactions with the residues comprising a hydrophobic wall 
near the active site.  Previous molecular dynamics simulations have proposed that Trp143 forms 
a cation-π interaction with the substrate, conferring additional stability to the meta- position 
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exclusively (11).   Migration of the Trp143 residue from binding to the adenosine motif of the 
SAM cofactor (as found in the crystal structure) to binding the side-chain of the catechol ligand 
demonstrates how the active site dynamics of COMT can modulate regioselectivity (31). 
 It is intriguing that an enzyme whose sole function is to degrade neurotransmitters and 
hormones displays specific regioselective behavior at the catechol moiety, a function in which 
site-specific chemistry seems unnecessary.  Additionally, it has been assumed throughout the 
literature that regioselectivity has been imposed by the enzyme alone and that the ligands 
themselves have no preference (1,9,12).  Here, we examine to see if the ligands possess intrinsic 
regioselective properties and whether the protein has adapted to take advantage of such 
properties by using regioselection as a method to enhance the rate of catalysis. Three models 
are constructed for this study: Model 1) a simple model composed of the catecholamine and 
trimethylsulfonium; Model 2) a model of catecholamine and trimethylsulfonium with four 
solvation shells of water; and Model 3) a model of the protein’s active site composed of the 
residues Trp143 and Lys144, Mg2+ coordinated to crystallographic water and surrounding 
residues, and the catecholamine and trimethylsulfonium. We compute the reaction barriers for 
methylating dopamine and levodopa at the meta- and para- positions using DFT since they 
represent two extremes of regioselection with meta/para ratios of approximately 4 and 16, 
respectively.  
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2. Methods  
 
2.1. Sequence conservation of COMT 
 
 Sequence alignments of COMT were performed for 13 different species: Homo sapiens, 
Mus musculus, Bos taurus, Equus caballus, Sus scrofa, Rattus norvegicus, Mycobacterium 
vanbaalenii, Pichia stipitis, Mycobacterium gilvum, Nicotiana tabacum, Salmo salar, Populus 
trichocarpa, Papaver somniferum, Thalictrum tuberosum.  The software ClustalX 2.0.10 was 
used to perform the alignment using the Neighbor Joining algorithm with default parameters. 
 
2.2. MD simulation of ligand complexes 
 
 The crystal structure of human soluble-COMT (PDB: 3BWM) was used as a starting 
point for our MD simulations.  A caveat of the crystal structure, as published by several groups, 
is that the inhibitor used to crystallize the protein has a different binding geometry compared to 
natural ligands.  Specifically, since most inhibitors decrease the nucleophilicity of the attacking 
oxygen with nitrate groups, these ligands bind bidentate to the Mg2+ in the active site.  Several 
groups have proposed that natural substrates of COMT contain a monodentate coordination 
number in the active site (10,11).  Additionally, the interaction between Trp143 and the ligand 
side chain is possible only after MD simulations (11). 
 Thus, we initially dock either dopamine or levodopa into the active site using the 3,5-
dinitrocatechol substrate position as a reference.  We adopt a similar simulation methodology as 
outlined by Kuhn et al in order to obtain our minimized complexes (11).  Briefly, we simulate 
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our system using the AMBER force field (amber03) and derived constraints for our ligands and 
S-adenosylmethionine using Antechamber (32).  Parameters for Mg2+ were adjusted according to 
Kuhn’s values; i.e., an atomic charge of +2, R*Mg = 0.7868 Å, εMg = 0.8751 kcal/mol.  The 
crystallographic water remains coordinated to Mg2+.  Additionally, the optimal nonbonded 
parameters between the attacking oxygen and donor sulfur were derived from Kollman (R*S = 
2.0000 Å, εS = 0.2500 kcal/mol).   
 Charges were assigned using RESP, with two Na+ counterions to neutralize charges, and 
the ligand was solvated with a 20 Å sphere of TIP3P water.  The counterions were over 16 Å 
away from the active site and were fixed to remove potential artificial long-range electrostatic 
effects.  Simulations were performed with a nonbonding cutoff of 16 Å, a time step of 1.5 fs with 
SHAKE, and at a constant temperature of 300 K using the Berendsen coupling scheme.   
 For the first minimization, the water molecules were relaxed for 1500 steps while all 
other atoms remained rigid.  The water was then equilibrated using MD simulation for 20 ps.  
Next, we progressively removed the positional restraints on the protein-ligand complex (from 25 
to 0 kcal/(mol Å2)) over a period of 4000 minimization steps.  The system then underwent MD 
equilibration for 20 ps.  To avoid loss of water near the vicinity of the protein-ligand complex 
due to diffusion, the water shell was stripped and a new 20 Å shell of TIP3P was added, 
minimized, and equilibrated as described above.  The protein-ligand complex was then 
minimized for another 4000 steps followed by an additional 20 ps of MD equilibration.  A final 
minimization of 2000 steps was performed to yield our final structure. 
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2.3. QM determination of reaction barriers 
 
 We used three different models to study the methylation reaction between 
levodopa/dopamine and trimethylsulfonium (a substitute for S-adenosylmethionine).  Model 1 
was constructed by modeling only the ligand and trimethylsulfonium.  Model 2 was constructed 
by taking Model 1 and adding four solvation layers of water, followed by minimization.  Model 
3 was generated from the minimized ligand pose generated using AMBER simulations of COMT 
with bound ligand (11,32).  We included residues coordinated to Mg2+ (as well as its 
crystallographic water), the catalytic Lys144, and the regioselective Trp144 in our final construct 
for Model 3.   In all models, the reaction coordinate is examined along the sulfur-oxygen axis.  
 Using a B3LYP functional, we performed a QST2 search for Models 1 and 3 to find the 
transition state of each methylation reaction (33).  A mixed basis set of 6-31G for C, H and 6-
311+G* for S, Mg, O, and N were used.  Reactants of each methylation reaction were computed 
by geometry optimization.  NBO analysis was used to examine the interaction energies between 
the two ligands.  In addition, a level-of-theory study was performed on Model 1 to monitor the 
effects of changing density functionals on our barrier height calculations.   
 We calculate the energies of the transition state and reactant for Model 2 by taking the 
transition state for the simple model in the gas phase and solvating it with four water shells.  The 
water was minimized using molecular mechanics, and then a single point calculation was done at 
the quantum level (using the same basis set) with the water treated using molecular mechanics.  
It is important to note that the single point calculations done in explicit solvent likely 
underestimate the stabilization due to the polarization of water since the dielectric response of 
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water is primarily determined by its orientational dynamics.  Nonetheless Model 2 serves as an 
estimate of the methylation reaction occurring in an aqueous environment. 
 
3. Results and discussion 
 
3.1. Residues involved in regioselection are evolutionarily conserved 
 
 Our sequence analysis shows that residues comprising the hydrophobic wall of COMT 
are conserved throughout evolution (Figure 3.1).  Many residues from the hydrophobic wall are 
as equally conserved as those coordinated to magnesium in the active site.  Trp143 is as equally 
conserved as the catalytic base Lys144, though Trp143 also is known to initially bind to the 
adenosine moiety of SAM.  For comparative purposes, we also show residues found in loops of 
the solvent accessible surface that expectedly have poorer sequence conservation.  
  High conservation of the hydrophobic wall residues suggests that its regioselective role 
is important for enzymatic function.  Regioselection is most commonly associated with chemical 
specificity, but from a biological standpoint there is no need for such specificity since the 
products are degraded after interactions with COMT and monoamine oxidase (in no specified 
order) (1).  The fundamental purpose of enzymes is to accelerate chemical reactions, and thus the 
conservation of regioselectivity has led us to hypothesize that COMT may have evolved 
regioselectivity as a method for chemical rate enhancement.   
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3.2. Reaction barrier differences between ligand conformations 
  
 The purpose of Models 1 and 2 is to deduce whether or not the ligands possess intrinsic 
regioselective properties, and what are the contributing components.  Model 3 mimics the active 
site environment to give insight into what extent the protein contributes to regioselection.  After 
obtaining the MD minimized structure for Model 3, we conducted DFT minimization using only 
the atoms described above.  Our final complex after DFT minimization supports the hypothesis 
from Kuhn et al that Trp143 is involved in a cation-π with the catechol side-chain, as we can 
directly observe this interaction when modeling quantum mechanically (Figure 3.2).   
 From our calculations, we observe higher reaction barriers for the para conformation of 
levodopa and dopamine that effectively slows its rate of methylation (Table 3.2, Table 3.3).  The 
energies calculated between Models 1 and 2 had no significant difference, likely due to utilizing 
a single-point calculation.  Meta-methylation becomes more favorable for levodopa when 
occurring in the active site, potentially underlying an important role for Trp143 in minimizing 
the reaction barrier.   
 Our comparison of different functionals on Model 1 calculations unanimously shows that 
the meta-methylation reaction is more favorable (Table 3.3).  Although there are large variations 
in how quantitatively accurate the barrier heights are, the qualitative trend clearly favors meta-
methylation for both ligands.  In our model of dopamine inside the active site of COMT (Model 
3), there is actually a 4 kcal/mol preference for para-methylation which is in opposition to 
experimental observations.  The meta/para ratio for dopamine is four times lower than the ratio 
for levodopa, and thus Model 3 of dopamine may be insufficient to detect such minor 
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differences.  Nonetheless, from Models 1 and 2 it can be concluded that it is the enzyme itself 
that is giving rise to regioselection as the ligand itself has no preference.   
  
3.3. Chemical differences between meta- and para- nucleophiles 
 The differences in reaction barriers alone do not give chemical insight into why 
regioselectivity takes place.  To investigate further, we perform an NBO analysis to calculate the 
interaction energies between the methyl donor and ligand using Model 1.  We find that the 
oxyanion in the meta TS is sp3 hybridized while the para oxyanion is sp2 hybridized.  As a result, 
the interaction energy between the methyl group and the oxyanion is significantly higher in the 
meta conformation (Table 3.4).   
 Chemical descriptors can describe the consequences of differences in oxyanion 
hybridizations (34,35).  The meta- nucleophile of each ligand is considered more electronegative 
and a harder base, indicative of it being a stronger nucleophile (Table 3.4).  Notably, the meta-
oxyanion of dopamine is still a more effective nucleophile than its para-oxyanion counterpart.  
Despite the increased nucleophilicity of the meta-oxyanion, the overall interaction energy 
between dopamine and trimethylsulfonium remains nearly identical for both conformations.  
Comparison of the total interaction energies between the ligand and methyl donor demonstrates 
that there is a significantly larger difference between the two conformations of levodopa as 
compared to dopamine (Table 3.4), consistent with experimental observations that levodopa has 
the higher meta-methylation preference (Table 3.1).   
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4. Conclusions 
 
 Our results propose that COMT utilizes regioselectivity not for the purposes of chemical 
specificity, but instead to enhance its catalytic rate by barrier minimization. Deprotonation of the 
3’ hydroxyl creates a more effective nucleophile and enables some ligands to confer 
regioselectivity as demonstrated by levodopa in our work.  COMT has evolved to take advantage 
of this property by selecting for residues that dock ligands preferentially in the meta-
conformation and thereby lowering the activation barrier for methylation. 
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Figure 3.1.  Sequence analysis of COMT shows high conservation of residues comprising 
hydrophobic wall. (Turquoise) Identical sequence conservation.  (Red) Similar sequence 
conservation. 
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Figure 3.2.  Transition state structures of COMT show Trp143 forming cation-π interaction 
exclusively in the meta conformation.  Residues coordinated to Mg2+ removed for clarity.  (a) 
Meta-methylation.  (b) Para-methylation. 
 
Tables 
 
Table 3.1.  Methylation of COMT Ligands 
 
 
R Ligand Meta/Para Ratio 
(12) 
-CH2CH2NH3+ Dopamine 4.2 
-CH2CH(NH3+)COO- Levodopa 15.4 
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Table 3.2.  Reaction Barriers and Energy Decompositions for Different COMT Ligands 
Conformationsa 
Ligand-Conformation (Model) ΔEe ΔExc ΔTS ΔE 
Levodopa-Meta (1) 11.9 33.2 -27.8 17.3 
Levodopa-Para (1) 22.0 27.0 -28.9 20.1 
Dopamine-Meta (1) 10.1 31.5 -24.8 16.8 
Dopamine-Para (1) 30.4 26.6 -31.9 25.0 
Levodopa-Meta (3) 37.9 36.8 -57.4 17.3 
Levodopa-Para (3) 33.7 41.2 -51.9 23.0 
Dopamine-Meta (3) 42.6 49.9 -58.3 34.2 
Dopamine-Para (3) 39.5 42.8 -52.2 30.2 
 
aUnits are in kcal/mol.  Legend: ΔEe ≡ electrostatic energy, ΔExc ≡ exchange-correlation energy, 
ΔTS ≡ kinetic energy, ΔE ≡ reaction barrier height. 
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Table 3.3. Performance comparison of difference density functionals on the transition state 
barrier height of the dopamine and levodopa reactions for the simplest model systems. Units in 
kcal/mol. 
 
 
 
 
    Dopamine   Levodopa    Dopamine       Levodopa 
 Meta- Para- Meta- Para- Meta-Para Meta-Para 
HF 58.57 66.19 59.41 62.14 -7.62 -2.74 
BP86 34.38 42.97 34.96 39.24 -8.59 -4.29 
BLYP 36.94 45.04 37.37 41.29 -8.09 -3.92 
TPSSTPSS 36.71 45.25 37.02 41.82 -8.54 -4.80 
MP2 40.67 47.57 41.06 45.65 -6.89 -4.60 
SVWN5 27.55 36.36 28.01 33.05 -8.81 -5.05 
VSXC 27.40 31.19 24.99 35.94 -3.79 -10.94 
B3LYP 42.18 50.18 42.70 46.49 -8.00 -3.79 
B3PW91 41.31 49.79 42.04 46.00 -8.48 -3.96 
B972 42.79 50.97 43.57 47.37 -8.18 -3.79 
O3LYP 43.91 52.11 44.90 48.14 -8.20 -3.24 
BMK 43.39 51.02 44.02 47.57 -7.63 -3.55 
BHandHLYP 48.49 56.29 49.11 52.45 -7.80 -3.34 
M062X 43.46 50.65 43.66 48.43 -7.20 -4.76 
tHCTHhyb 38.95 47.21 39.55 43.86 -8.26 -4.32 
X3LYP 42.06 49.97 42.55 46.38 -7.91 -3.83 
CAM-B3LYP 45.33 53.30 45.94 49.56 -7.98 -3.62 
B2PLYP 41.21 57.95 41.59 45.73 -16.74 -4.14 
mPW2PLYP 41.75 49.25 42.13 46.27 -7.51 -4.14 
LC-wPBE 47.48 55.75 48.42 51.99 -8.27 -3.57 
HSE2PBE 40.34 48.57 41.00 45.03 -8.23 -4.04 
B1LYP 43.68 51.58 44.20 47.87 -7.90 -3.67 
wB97X 44.53 52.04 45.25 48.88 -7.51 -3.62 
wB97XD 42.03 49.68 42.64 47.13 -7.64 -4.49 
LC-BLYP 48.13 56.20 48.89 52.30 -8.07 -3.41 
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Table 3.4.  Conceptual DFT Descriptors and NBO Analysis for Model 1a 
Ligand-Conformation Eint  χ η 
Levodopa-Meta 62.3 23.9 72.8 71.5 
Levodopa-Para 37.9 2.7 64.0 55.8 
Dopamine-Meta 48.9 26.7 70.9 70.9 
Dopamine-Para 51.6 5.2 60.2 69.0 
 
aUnits in kcal/mol.  Legend: χ ≡ electronegativity, η ≡ chemical hardness, Eint ≡ total interaction 
energy between SAM and ligand,  ≡ interaction energy between oxyanion and methyl group. 
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Supporting Information 
 
Figure 3.S1.  Calculated transition states for Model 1 of Levodopa and Dopamine 
conformations.  Model 2 uses the same transition states but in addition contains four additional 
solvation shells of water.  Legend: hydrogen (white atoms), carbon (grey atoms), oxygen (blue 
atoms), and sulfur (yellow atom).   (a) Dopamine Meta-Methylation.  (b) Dopamine Para-
Methylation.  (c) Levodopa Meta-Methylation.  (d) Levodopa Para-Methyation. 
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Figure 3.S2.  Active site model of methylation.  Dopamine methylated at the para position by 
trimethylfulonium is shown as an example. Legend: hydrogen (white atoms), carbon (grey 
atoms), oxygen (blue atoms), sulfur (yellow atom), and magnesium (green atom). 
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Conceptual DFT 
 Conceptual DFT is useful in obtaining qualitative chemical insight from quantum 
chemical calculations (34,35).  In this work we have considered several chemical descriptors.  
Chemical hardness is traditionally defined as the difference between an atom’s ionization 
potential and electron affinity.  Applying Koopman’s Theorem, we can approximate the hardness 
in DFT as 
 
which is simply the energy difference of the HOMO-LUMO gap.  Similarly, we can then define 
the electronegativity as 
 
Traditionally the energy in DFT has been decomposed as  
 
where TS, Ee, and Exc are the noninteracting kinetic, electrostatic, and the exchange-correlation 
energies respectively.  Alternatively, we can decompose the energy difference as  
 
where the individual differences arise from steric, electrostatic, and quantum contributions 
respectively.  The steric contribution arises from the Weizsäcker kinetic energy 
 
and the quantum contribution is 
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ABSTRACT 
 Catechol-O-methyltransferase (COMT) is a major enzyme controlling catecholamine 
levels that plays a central role in cognition, affective mood and pain perception.  There are three 
common COMT haplotypes in the human population reported to have functional effects, 
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divergent in two synonymous and one nonsynonymous position.  We demonstrate that one of the 
haplotypes, carrying the non-synonymous variation known to code for a less stable protein, 
exhibits increased protein expression in vitro. This increased protein expression, which would 
compensate for lower protein stability, is solely produced by a synonymous variation (C166T) 
situated within the haplotype and located in the 5’ region of the RNA transcript.  Based on 
mRNA secondary structure predictions, we suggest that structural destabilization near the start 
codon caused by the T allele could be related to the observed increase in COMT expression.  Our 
folding simulations of the tertiary mRNA structures demonstrate that destabilization by the T 
allele lowers the folding transition barrier thus decreasing the probability of occupying its native 
state. These data suggest a novel structural mechanism whereby functional synonymous 
variations near the translation initiation codon affect the translation efficiency via entropy-driven 
changes in mRNA dynamics and present another example of stable compensatory genetic 
variations in the human population. 
 
 
INTRODUCTION 
 Catechol-O-methyltransferase (COMT) deactivates neurotransmitters and metabolizes 
catechol-containing structures by methylation of a hydroxyl group (12).  The implications of 
COMT activity are broad and can influence factors such as general cognitive function (24,36,37), 
addiction (25), stress response (25), and pain sensitivity (13).  Three genetic variants of COMT 
have been identified in the human population corresponding to low, average, and high pain 
sensitivity haplotypes (LPS, APS, and HPS) (13).  Higher COMT activity corresponds to lower 
pain sensitivity and vice versa.  A silent mutation differentiates between low (LPS) and high 
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(HPS) pain sensitive phenotypes via reduced HPS protein levels (15), while APS is characterized 
by a valine to methionine substitution at amino acid position 108 that reduces its intrinsic activity 
through lowering protein stability (12,16) (Fig. 4.1A).  These haplotypes have also been 
associated with risk of fibromyalgia (18), temporomandibular joint disorder (TMJD) (13), 
postsurgical pain (38,39), responses to drugs (20) and development of brain white matter (21).  
 The ability of highly structured regions of mRNA to inhibit protein expression was 
recognized for a long time (40-42).  However, the exact mechanisms of this inhibition and its 
relative contributions to regulation of translation efficiency in live cells have only limited 
examples (43,44).  Thus, several in vitro studies have shown that RNA transcripts containing 
extremely stable stems with melting temperatures higher than 70°C can decrease protein 
expression at the level of ribosomal translocation (45).  The underlying factor preventing 
translation at highly stable regions is thought to be the ribosome itself.  It has been shown that 
the ribosome contains an intrinsic helicase activity allowing it to read the individual bases (45).  
Thus, RNA motifs that are too difficult to unwind cause the ribosome to stall on the transcript.   
 Protein synthesis is highly regulated at the initiation stage enabling rapid, reversible and 
spatial control of gene expression (46-49).  Prokaryotic translation of mRNA is regulated at both 
the 5’ and 3’ ends of a transcript during initiation(50).  For eukaryotes, initiation of translation 
proceeds by the ribosome scanning from the 5’ end of the transcript to the initial start codon 
(41,51).  Scanning through the transcript is facilitated by the eIF4 factor unwinding structured 
RNA regions through an ATP-dependent process (40), and because of the scanning mechanism 
ribosomes cannot bind circular mRNA transcripts (52).  Earlier work has demonstrated that gene 
expression can be repressed by increasing the stability of 5’ end mRNA secondary structures 
(53).  Recent experiments with GFP constructs have also shown that the folding free energy of 
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the 5’ end of an mRNA transcript is most correlated with protein expression, as opposed to a 
codon bias (54).  Furthermore, reduced stability of the mRNA at the translation-initiation site 
was found to be a common feature for most species (55). 
 To uncover the translation mechanisms that allelic variants of common COMT 
haplotypes contribute to variation in COMT activity, we performed a set of molecular and 
computational studies.  We first conducted in vitro translation studies of three haplotypes in 
rabbit reticulocyte lysates.  Unlike the in vivo expression system, we did not observe a difference 
in an amount of translated COMT protein between LPS and HPS haplotypes, suggesting that 
rs4818-dependent stem-loop structure (15) requires additional cellular chaperons to affect 
translation efficiency.  However, we observed robust increase in amount of protein of APS 
haplotype-coded mRNA. Here we show how APS haplotype-specific T allele of the SNP rs4633 
located at the 5’ end of mRNA near the ribosomal binding site, rather than non-synonymous 
met158 variation, modulates protein expression in vitro. We also conduct secondary structural 
analysis and perform simulations at the 5’ end of each haplotype using discrete molecular 
dynamics to determine the mechanism by which the T allele at rs4633 alters translational 
efficiency (46,56,57).  Our results reveal a novel mechanism by which the dynamics of mRNA 
structures near the initial start codon may influence efficiency of translation initiation. 
 
MATERIALS AND METHODS 
In Vitro Translation 
 COMT cDNA coding for three haplotypes and LPS-T166 mutant were cloned into a 
pCMV-Sport6 vector as described previously (15).  The mRNA templates used for translation 
were generated by first restriction enzyme digestion using HindIII to create a linear plasmid.  
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Digested plasmids were subsequently cleaned up using a PCR purification kit (Qiagen).  In vitro 
transcription was performed by adding SP6 RNA polymerase (Promega) along with rNTPs and 
incubated in a reaction buffer under conditions provided by the manufacturer.  RNA was purified 
from the mixture using Trizol (Invitrogen) and subsequently dissolved in water.   The RNA 
integrity was evaluated by running the samples on the Bioanalyzer 2100 (Agilent).   
 The in vitro translation reaction was carried out using 1 µg RNA template, 17.5 µL rabbit 
reticulolysate, 0.5 µL amino acid mixture (-Met), 1 µL 35S-labeled Methionine (1200 Ci/mmol), 
0.5 µL RNasin, and diluted to a total reaction volume of 25 µL. To denature the RNA we heat up 
the samples for 3 minutes at 70°C and immediately place on ice.  For RNA secondary structure 
formation, we heat denature then subsequently add 5 mM MgCl2 and cool at a rate 0.1°C/sec to a 
final temperature of 15°C.   Once the RNA template is added to the rabbit lysate mix, we 
incubate for 1.5 hours at 30°C.  The reaction is stopped by adding 1x Laemmli buffer and 
heating for 4 minutes at 80°C.     
 We quantified the amount of protein product by separating via SDS-PAGE.  The gel is 
initially placed in fixing solution (50% methanol, 40% water, 10% acetic acid) for 30 minutes 
under gentle rotation.  Afterwards the gel is soaked in a rinsing solution (85% water, 7% 
methanol, 7% acetic acid, 1% glycerol) for 5 minutes with gentle rotation.  The gel is then placed 
in a drier with vacuum pump for 1.5 hours at 80°C.  The gel is then placed in a cassette with 
PhosphorImager screen and later quantified using Storm PhosphorImaging System (Molecular 
Dynamics). 
 To verify that our radiolabeled protein product is COMT, we performed 
immunoprecipitations on several lysate reactions.  After in vitro translation reaction, an equal 
amount of NET buffer (150 mM NaCl, 5 mM EDTA, 50 mM Tris-HCl, pH 7.4) is added.  We 
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use Ultralink Protein A/G agarose beads and equilibrated them by washing with 0.5 mL NET 
buffer twice per 100 µL beads and resuspending in 100 µL NET buffer.  For each lysate reaction, 
5 µL of primary COMT antibody were added and incubated overnight with rotating at 4°C.  
Then 50 µL of equilibrated Protein A/G agarose beads are added and incubated at 4°C for 4 
hours.  Samples are then centrifuged for 5 minutes to remove the supernatant.  The supernatant is 
saved for further SDS-PAGE analysis.  The beads are then subsequently washed with 50 µL 
NET buffer twice by rotating for 5 minutes in 4°C.  The proteins are removed from the beads by 
dissolving them with 25 µL of Novex Tris-Glycine SDS solution and boiled for 4 minutes at 
80°C.  The supernatant from the boiling reaction contains our immunoprecipitated protein and is 
analyzed via SDS-PAGE.   
 
Transfection and Western Blotting 
 The cDNA clones coding for three COMT haplotypes were transfected into mammalian 
cell lines as described previously (15). COS-1, Hek-293, HepG2, and MCF-7 cell lines were 
purchased from ATCC and maintained in media (DMEM with 10% FBS, 4.5g/L glucose, L-
glutamine, and sodium pyruvate for COS-1, Hek-293, and HepG2; RPMI 1640 with 5% FBS and 
L-glutamine for MCF-7) in accordance with manufacturer’s recommendations. The Western 
blotting was performed as described previously (15) using anti-hCOMT antibody derived from 
rabbit (Chemicon, ab5873). 
 
Secondary Structure Analysis of COMT Allelic Variants 
COMT allelic variants and randomly generated sequences were computationally ‘folded’ 
and the predicted minimum free energy of the secondary structure was calculated for different 
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window sizes, using our implementation of the algorithm described by Zuker (57). Energy 
minimization was performed by dynamic programming method using an improved algorithm for 
evaluation of internal loops (58). 
 We estimated the free-energy penalty associated with breaking (opening) of the target’s 
local secondary structure (target structure opening, ΔG kcal/mol), considering local disruption of 
secondary structure in windows with different lengths. Free-energy changes were approximated 
with nearest-neighbor free energy parameters using the program OligoWalk (59). Here, we 
consider local structure for a set of suboptimal structures (Fig. 2A). Each structure contributes to 
the free energy penalty for disruption of structure in proportion to a Boltzmann weight; and the 
summations over all suboptimal structures were provided. Thus, this difference between the free 
energy of each suboptimal structure and the free energy of the corresponding suboptimal 
structure without base pairs in the region of complementarity in 30-nt window length is defined 
as the energy required for target structure opening (Fig. 2A). Monte Carlo simulation and 
analysis of randomized sequences (47,60) was used for estimation of the significant difference 
between target structure opening, ΔG, of two COMT allelic variants.  One-thousand unique 
random sequences for each allelic variant were generated by shuffling the first 210 nucleotides of 
the COMT mRNA sequence and iteratively mutating two positions randomly along the sequence 
(except position 166).  Each generated sequence is then checked to verify that the %GC and 
%AU content remain identical to the original COMT gene.  Once the sequences are cross-
checked with one another to ensure there are no duplicates, we create two sets of sequences 
where position 166 is occupied by either a C or U. The free-energy penalty associated with 
opening of the target’s local secondary structure (ΔG kcal/mol) for all random sequences, 
considering local disruption of secondary structure in windows with 30-nt length was calculated.  
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P-values for randomizations and for difference between the C and T alleles were determined by 
paired t-tests. 
 
Discrete Molecular Dynamics 
 Traditional molecular dynamics simulate the motions of particles by solving Newton’s 
equations of motion for a defined system using an integration algorithm.  In DMD, simulations 
proceed according to the conservation laws of energy, momentum, and angular momentum and 
are evaluated as a series of two-body interactions.  The efficiency of the engine is based on an 
algorithm that searches through an event table, where velocities are only modified as necessary.  
Here we classify an event as the instance in which two particles are within a defined interaction 
range as defined by their potential.  The potentials used in DMD are discretized to accommodate 
the discontinuous nature of the simulations.   
 Let us consider a system of particles, including two particles i and j both of mass m that 
occupy initial positions of ri0 and rj0 with initial velocities of vi and vj.  For simplicity we discuss 
a scenario where the interaction potential consists of one step, otherwise known as a square well 
potential, defined as 
 
The variable σα defines an interaction distance, where α = 1 refers to the hard sphere repulsion 
and α = 2 is the attractive interaction.  During a simulation, a table is generated by calculating 
event times for each pair of particles.  The time interval in which an event may occur between 
two particles is  
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where  
 
 
 
and the plus-minus sign refers to two particles either approaching or receding from each other, 
respectively.  The trajectory of particle i is evaluated with respect to time as  
 
where the time unit tu is determined by comparing the shortest event time to the maximum 
allowed time interval tm.  If  is greater than tm, then the particles are only permitted to move 
for tm and a new table is subsequently generated.  Otherwise the shortest event time is the first 
considered, and the velocity changes according to the conservation laws of energy and 
momentum.   
 When particles i and j are determined to interact at , the squared difference in the 
particles’ positions is compared to the squared interaction distance prior to a change in the 
potential (i.e., before ).  There are three possible scenarios for our one-step potential 
as the two particles approach one another.  During an attractive encounter, if  then the 
magnitude of separation between the particles decreases and the change in velocities will be  
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However if , then the two particles increase their magnitude of separation and the change 
in velocities will be 
 
In the case of hard sphere repulsions, the change in velocities is simply 
 
 After each event, we remove from the table events that were calculated with the previous 
two particles since their velocities and positions have changed.  The number of possible events 
with these two particles are then recalculated and sorted within the table.  Simulations then 
proceed through the table, where particles are allowed to move between time intervals, until 
either  < tm or the table of events is depleted. 
 We incorporate the Andersen thermostat to simulate under canonical (constant N, V, T) 
conditions (61).  Temperature is maintained constant by surrounding the system of particles with 
a heat bath.  The heat bath itself is comprised of imaginary ghost particles (62,63) with number 
density ρg that undergo stochastic collisions with the system via a Poisson process 
 
 Here P(t) represents the probability that a randomly chosen particle within the system 
undergoes a collision with a ghost particle at time t.  The constant q represents the rate at which 
system particles undergo collision with the ghost particles.  This may also be referred to as the 
heat exchange rate, which is determined by  
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The momentum of a particle after collision with a ghost particle at tu is selected randomly from a 
Boltzmann distribution of values at temperature T.   
 
Three-bead RNA Model 
 We perform the RNA folding simulations using a simplified 3-bead model (freely 
available on the web at http://ifoldrna.dokhlab.org/) (56).  For each nucleotide, each bead 
represents a phosphate, sugar, and base.  Interactions contained in the model include standard 
Watson-Crick base pairing, G-U base pairing, base stacking, phosphate-phosphate repulsion, 
hydrophobic interactions, and loop entropy.   
  
Replica-Exchange Simulations and Analysis 
 To ensure adequate sampling of the conformational space of each haplotype, we utilize 
replica-exchange where R replicas are simulated each at a temperature Ti where i represents the 
index of that particular replica (64).  A random walk in temperature space is performed by 
exchanging the temperatures between two replicas i and j under the probability 
 
where 
 
and Ei is the total energy of the system within the ith replica.   Thus as the macromolecule 
explores conformational space, the energy changes accordingly.  Swapping the temperatures 
between replicas allows conformations that are stuck in local energy minima to escape and 
resume exploring other conformations.  For our RNA folding simulations, we performed replica-
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exchange simulations with nine replicas (T = 0.1, 0.15, 0.2, 0.225, 0.25, 0.275, 0.35, 0.4, and 0.5 
ε/kB) per allelic variant for 2 x 106 time steps.  Energies of each RNA conformation throughout 
the simulation are evaluated according to parameters published previously (56). 
 Simulations can be analyzed using the weighted histogram analysis method (WHAM) to 
determine various thermodynamic quantities by deriving a partition function using the 
trajectories (65).  We compute the specific heat of folding using 
 
where < E > is the average potential energy and < E2 > is the average squared potential energy of 
the system for each specific temperature (62). 
 Contact maps provide a useful measure of gauging the frequency of certain 
conformations over the simulation. For our purposes, we are interested in the frequency of base 
pair formations and thus have limited our contacts to the base beads (as opposed to including the 
sugar and phosphate beads).  We define a base pair between two atoms i and j > i+3 as less than 
6.5 Å. From the contact maps, we can compare structures derived from simulations to secondary 
structure prediction programs by comparing contact maps of the former to dot plots of the latter.  
We can also deduce the secondary structures from the tertiary structures by calculating base pairs 
formed for each trajectory according to the parameters in the force field and determine which 
secondary structures are most probable (56).    
 We have clustered conformations using the OC hierarchical clustering package (available 
at http://www.compbio.dundee.ac.uk/downloads/oc).  RNA structures derived from our 
simulation trajectories were clustered according to RMSD.  The lower the RMSD between two 
RNA structures, the less distant (in terms of clustering) they are from one another.  The OC 
algorithm works by first taking two structures that have the minimum distance and assigning 
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them as a cluster, and then search across all other structures and comparing their distances 
amongst other structures.  Structures that have been clustered together are considered a single 
entity.  Representative tertiary structures were derived from three clustering methods: single 
(where the minimum distance between the two clusters is taken as the distance), complete (where 
the maximum distance between the clusters is taken as the distance), and means (where the 
average distance between clusters is taken as the distance).  Structures that were found to be 
most dominant for all three clustering methodologies were considered most representative.   
 
 
RESULTS 
In vitro translation of COMT haplotypes 
 To study the precise molecular mechanism(s) whereby the mRNA of COMT haplotypes 
(Fig. 4.1) produce different protein levels, we first employed an in vitro translation approach that 
is very effective in isolating putative mechanisms involving differential effects at the ribosomal 
level. We performed an endpoint kinetics assay using rabbit reticulocyte lysates.  The advantage 
of this in vitro system is that external biological factors that regulate protein synthesis are absent.  
We found that the APS haplotype demonstrates higher protein expression levels compared to 
both the LPS and HPS haplotypes while LPS and HPS haplotypes have equivalent expression 
levels in vitro (Fig. 4.1B).   
 There are two unique alleles an APS haplotype carries within its transcribed region – a T 
allele of the SNP rs4633 at the 5’ end of the mRNA (+32 nt downstream from the start codon) 
and an A allele of the SNP rs4680 within the second exon of the gene (Fig. 4.1A).  As we 
previously showed, the structural mRNA differences within the second exon are the most 
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pronounced between LPS and HPS haplotypes (15), not the APS haplotype. Consequently, we 
concluded that it is unlikely that SNP rs4680 contributes significantly to the protein levels in the 
in vitro translation experiment.  In contrast, SNP rs4633 is situated at the 5’end of the COMT 
mRNA near the start codon; a region which showed the strongest association between stability of 
mRNA folding and the rates of translation initiation expression levels of individual genes 
(54,66).    To test the individual contribution of SNP rs4633 in the increase in protein levels 
observed for APS haplotypes, we created a C to T mutant at position 166 for LPS haplotype 
(LPS-T166). Our results show that mutating LPS at position 166 from C to T recapitulates high 
expression levels characteristic for APS (Fig. 4.1B).  Thus the determining factor for translation 
efficiency of COMT resides in the SNP rs4633 alone.   
 
 
Secondary structure prediction of 5’ region 
 We then studied local RNA secondary structures contributing to effect of SNP rs4633.  It 
was shown that free energy stability of the 5’ region of an mRNA transcript is correlated with 
translational efficiency (47,48,54,66-68).   Transcripts that have less stable RNA structural 
elements near the 5’ end have higher translation rates (54), presumably because tight binding to 
the initial start codon becomes difficult for the ribosome initiation machinery (46,49,51,54).  To 
test if the T allele of rs4633 specific for APS haplotype results in a change in free energy, we 
initially utilize secondary structure prediction programs to calculate the free energy of the 5’ end 
for different respective RNA. 
 We predicted mRNA local secondary structures in the vicinity of the SNP rs4633 and the 
start codon by employing different algorithms for both variants (56,58,69).  Comparison of the 
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optimal structures for both C and T-allelic variants shows that the main structural differences due 
to the SNP rs4633 lies within the structural regions of Loop I, Stem I and Stem II (Fig. 4.2A; 
Supplementary Material, Figs. 4.S1-4.S3).  Loop I of the 166T variant (nt 119-126) is more 
flexible with an additional two nucleotides (nucleotides 126 and 127) comprising this single-
stranded region.  The two nucleotides present in Loop I of the 166T variant causes Stem I to lose 
two Watson-Crick base pairs and lower the stem’s stability.  Consideration of these two regions 
alone, the T allele-carrying mRNA is less stable. However, both free energy calculations predict 
that its structure at Stem II downstream from the start codon is ~1 kcal/mol more stable than the 
wild type.  This is primarily due to an additional A-U base pair formed unique to the T allele-
carrying mRNA in Stem II between nucleotides 156 and 165 that increases its stability from an 
enthalpic standpoint.  From visual inspection, it can also be seen that the additional unpaired 
bases found in the hairpin loop of Stem II for 166C variant are entropically disfavorable due to the 
number of single-stranded nucleotides comprising the terminal loop compared to only four base 
pairs within the stem.   
 To verify whether this structural region is stable independent of the surrounding 
sequence, we truncated the sequence near the neighboring junctions (nucleotides 119 through 
171) and refolded the structures using Mfold, Afold and RNAstructure (57,58,69).  All programs 
predict the same optimal local structures as the 210 nt length transcripts (Fig. 4.2A).  
Furthermore, we predicted all suboptimal structures for both C and T allelic variants when 
percent suboptimality is set to 30 (when only folding within 30% from the minimum free energy 
will be computed).  Identical Stem I loops surrounding AUG codons were found in two most 
stable RNA local structures with the total free energies (∆G) of -14.8 and 8.63 kcal/mol in the 
166C-allelic variant, respectively (Fig. 4.S4).   The 166T-allelic variant produced four structures 
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with the energies ranging from ∆G=-16.6 kcal/mol to ∆G=-10.05 kcal/mol, only one of those 
identical at Stem I loop (Fig. 4.S5).  Thus, there are not only differences in the secondary 
structures between 166C and 166T allelic variants, but 166T-allelic variant also produces a higher 
diversity of suboptimal structures. 
 We then estimated the level of pairing and free energy of target breaking (opening) for 
the 166C-allelic variant mRNA and the 166T variant using full length transcripts and truncated 
transcript sequences of different lengths starting from 210 nucleotides, where approximately a 
half of the sequence length is located in the 5’UTR and the second half is in the coding region of 
the COMT gene. We modeled the dynamic process of transcript folding and target breaking 
using 30 nucleotide windows (59,70) (see Materials and Methods). Profiles of the free energy 
of target breaking for 166C and 166T variants (Fig. 4.2B) show that mRNA secondary structures in 
the vicinity of the start codon (30-nt length window) are less stable and the free energy of target 
breaking is significantly (P = 0.0016) higher for the 166T variant of rs4633 (specific for APS 
haplotype) relative to the 166C variant of rs4633 (specific for LPS and HPS haplotypes). On the 
other hand, Monte Carlo simulation of the sequences in the vicinity of the start codon showed 
that the differences in free energy of mRNA secondary structure target opening for the 166T 
variant and the 166C variant of rs4633 were not random (P < 0.05).  Consistent with these 
findings, our secondary structural analysis using Mfold, Afold and RNAstructure (57,58,69) also 
demonstrates that the allelic variation of rs4633 directly affects the RNA structure surrounding 
the start codon (Fig. 4.2B).  Thus, our secondary structure predictions thus provide an important 
insight that there is an independent motif in which there are structural differences for each 
haplotype.   
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Simulations predict different folding barriers 
 Our folding prediction and analysis of mRNA local secondary structures revealed that the 
166T allele promotes base pair disruption near the vicinity of the start codon (Fig. 4.2B).  The 
lower free energy stability of the 166T-allelic variant implies that there exists a lower energy 
barrier separating the folded and unfolded states.  The eukaryotic initiation factor eIF4a 
facilitates translation in an ATP-dependent manner by unwinding RNA secondary structure to 
enable ribosomal translocation (40).  Thus if there are differences in the energetic barriers 
between the folded and unfolded states for the haplotypes, then structures with a lower energy 
barrier height would undergo more efficient translation since there would be a higher probability 
for the structure to exist in an unfolded conformation (71,72).  To test this hypothesis, we 
generate tertiary structures of the RNA motifs by simulating the dynamics (Fig. 4.3A,B) of each 
allelic variant using discrete molecular dynamics (DMD) (56).  
 Simulations were performed for both 166C and 166T-allelic variations of rs4633 of COMT 
transcripts at the 5’ region between nucleotides 119 through 171 using an RNA three-bead model 
(56).  Since we observe multiple transitions between the folded and unfolded states, there is 
adequate sampling to enable determination of the thermodynamics of the folding transition using 
the weighted histogram analysis method.  A comparison between the 166C and 166T alleles of 
mRNA transcripts shows that the peak denoting the folding transition temperature is slightly 
higher for the 166C allele, demonstrating its increase in thermodynamic stability (Fig. 4.3C).   
 We find that both alleles adopt a native conformation (Fig. 4.3A,B) that is in line with 
secondary structural predictions (Fig. 4.2A).  Both the C and T alleles fold into their respective 
native conformations at -25.1 kcal/mol and lower (Fig. 4.3D).  Notably, the 166C allele has a 
higher probability in existing in this low energy state.  The most stable structures that are unique 
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to the 166C allele are formed due to transient base pair formations in the loops of Stem I and Stem 
II (Fig. 4.3D).  In contrast, the 166T allele-carrying mRNA is more likely to adopt conformations 
at higher energies along its folding pathway (Fig. 4.3D); a consequence of its lower folding 
transition temperature (Fig. 4.3C). 
 Since we know that the T allele is responsible for disrupting the local secondary structure 
near the start codon (Fig. 4.2B), we wanted to deduce the destabilizing effects on the overall 
tertiary structure of that region.  From our simulations, we determined the flexibility of each 
allelic variant’s tertiary structure by calculating the root mean square fluctuation (RMSF) of the 
native ensemble (as highlighted in Fig. 4.3D).  We find that the dynamics of 166T allele-carrying 
mRNA are highly entropy driven (Fig. 4.3B; right most structure) with RMSFs up to 11 Å for a 
single nucleotide (Table 4.S1).  In contrast, the 166C allele-carrying mRNA has a RMSF less than 
6.5 Å for all nucleotides (Fig. 4.3A; Table 4.S1).  The contact map highlights the attempts made 
by 166T allele-carrying mRNA to fold into its native structure (Fig. 4.3E,F).   The plethora of 
contacts demonstrates the competing states that lead to a rugged energy landscape (Fig. 4.3D).  
Thus, examining the dynamics of 166T allele-carrying mRNA suggests that the free energy barrier 
height between folded and unfolded states is smaller (Fig. 4.3C) and therefore likely to adopt 
higher energy states.  Consequently, the 166T allele exists in an unfolded intermediate state more 
frequently than the 166C allele-carrying mRNA (Fig. 4.3D) (71-73).    	  
Haplotype-dependent COMT Protein Expression in Mammalian Cell Lines  
 To examine if the higher efficiency of protein translation contributed by the 166T allele 
plays a substantial role at the cellular level, we carried out a series of transfection studies.  As 
reported previously, in PC12 rat pheochromacytoma cells, COMT protein expression levels is 
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reduced 25-fold in the HPS haplotype; however, LPS and APS haplotypes display comparable 
protein levels (15).  To determine whether this effect is a general feature of COMT protein 
expression in mammalian cells or specific to the PC12 cell line, we transfected expression 
vectors with the three COMT haplotypes in a number of different cell line with divergent tissue 
origin: COS-1 monkey kidney cells, HEK-293 human embryonic kidney cells, HepG2 human 
liver cells, and MCF-7 human breast cancer cells.  We find that all transfected cell types 
consistently exhibited the same qualitative trend in protein expression (Fig. 4.4), where LPS 
exhibits higher protein expression than HPS, and HPS shows the most reduced protein 
expression.  Notably, APS showed comparable protein levels to LPS in COS-1 and HepG2 cell 
lines but not in HEK-293 and MCF-7 where APS showed the highest protein level (Fig. 4.4). 
Thus, it appears that an increase in translation efficiency of the APS haplotype does contribute to 
cellular protein levels and this contribution is tissue-specific.   	  	  
 
DISCUSSION 
166T mutation contributes to higher translation rates  
 Our in vitro translation data demonstrate that the APS haplotype of COMT has a higher 
rate of translation compared to LPS and HPS, while LPS and HPS haplotypes show similar level 
of expression (Fig. 4.1B). Furthermore, our results suggested that the upstream 5’-end structure 
in allelic dependent manner largely controls the in vitro translation rate.  The APS-specific 166T 
allele of rs4633 was hypothesized to drive the difference in protein translation efficiency. The 
166T allele of rs4633 was also a strong candidate for the translational “switch” because of its 
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unique location near the start codon, the RNA area known to contribute the most to the RNA 
structure-dependent translation initiation rate (54).  To test this hypothesis, we created a LPS 
mutant carrying the 166T allele of rs4633 (LPS-T166) specific for APS haplotype.  This mutant has 
similar protein expression levels in comparison to APS (Fig. 4.1B), suggesting that only the SNP 
rs4633 is necessary for determining expression rates in vitro.  Therefore in the case of translation 
in vitro, we can rule out the possibility that the other downstream SNPs of three major COMT 
haplotypes play a role in determining efficiency of in vitro translation. 
 
Computational analysis reveals structural differences 
 To investigate the structural mechanism in which SNP rs4633 affects in vitro translation 
of COMT RNA, we employed an array of computational approaches.  We initially utilize Mfold 
to generate secondary structures of each haplotype.  By examining the folds of COMT mRNA at 
various sequence lengths, we observe which type of structures predominate at the 5’ end.  We 
find that much of the structure toward the 5’ end is identical for all haplotypes with the exception 
near the vicinity of the SNP rs4633 and start codon (Fig. 4.2B).  The observation that a single 
SNP affects the 5’ end structure in the vicinity of the start codon supports the view that this 
region might regulate COMT translation.   
 LPS and HPS haplotypes exhibit equivalent in vitro protein expression levels, which can 
be attributed to identical secondary structures near the start codon due to sharing the 166C allele.  
However, the 166T allele structure (carried by the APS haplotype) has some unique structural 
rearrangements in comparison with the 166C-allelic variant that influences structure stability in 
the vicinity of the start codon (Fig. 4.2A).  Furthermore, consistent with these observations, 
thermodynamic analysis from OligoWalk suggests that the 166T allele structure is less stable near 
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the vicinity of the start codon compared to the 166C allele (Fig. 4.2B).  Local secondary structures 
are extremely conserved in the vicinity of the start codon for the 166C allelic variant, exemplified 
in the optimal and suboptimal structures predicted by Mfold where Stem I is identical for both 
(Fig. 4.S4).  Contrarily, local secondary structures in the vicinity of the start codons differ 
between optimal and suboptimal structures in T-allele and display more structural diversity.  
  It is suggestive that the region in the vicinity of the start codon may potentially play a 
more significant role in regards to translational efficiency (54,67).  Since we know that the 
alternative 166T allele yields a unique structure in the vicinity of the start codon, it is possible to 
fold this sequence using DMD simulations and seek whether tertiary interactions may play an 
integral role.  We find that both 166C allele and 166T allele predicted structures derived from 
DMD simulations are identical to secondary structures predicted by Mfold and RNAstructure 
(Fig. 4.2A; 4.3A,B).  However, the native ensemble of 166T allele is less probable in comparison 
to the 166C allele.  The conformational entropy for the 166T allele is higher than the 166C allele, 
resulting in high flexibility and exploration of higher energy states (Fig. 4.3D).  Consequently 
this may enable facilitated initiation of translation as displayed by the higher expression levels by 
this haplotype.  Our thermodynamic analysis reveals that this is a strong possibility given that the 
folding transition temperature is lower for 166T allele’s structure than 166C.   
 
Codon bias and mRNA structure as factors in translation efficiency 
 Two main mechanisms are thought to be important factors in determining the efficiency 
of mRNA translation: 1) the ease of unwinding the mRNA structure at the 5’ end and 2) codon 
usage.  The extent to which one mechanism plays a dominating factor over the other is 
dependent upon the individual genes in question (53,54,74,75).  Our simulations in this work 
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have focused on the structural contributions that can lead to increased protein expression from 
the 166T allele.  Here we consider the possibility of codon bias and its effect on translational 
regulation of COMT.  Both the 166C allele and 166T allele at rs4633 code for histidine through the 
synonymous codons CAC and CAT, respectively.  It has been reported that the CAC allele is 
nearly twice as efficient compared to the CAT allele (76).  Within this context, it is unlikely that 
the CAT codon is the contributing factor for increased protein expression.  However, it has also 
been reported that use of low efficiency codons near the initiation site can aid the efficiency of 
translation as this scenario prevents ribosomal traffic jams near the initiation site (77).  It is 
uncertain to what extent the CAT codon increases efficiency of translation given these two 
competing scenarios. These explanations are in agreement with previously published data on the 
role of mRNA structure and codon usage in the vicinity of the start codon for translation 
efficiency (68).  Nevertheless, reduced ribosomal traffic may also play a role in the enhancement 
of 166T allele protein expression. 
 
Role of mRNA stability and dynamics in translation initiation 
 Previous reports have only suggested a correlation of free energy stability and 
translational efficiency (41,54).  Since it is the stability of the 5’ end that is the most determining 
factor for translation efficiency, it is presumed that the limiting factors are unwinding by the 
eIF4a factor and ribosomal binding to the start codon.  The relationship between free energy and 
translation initiation is not immediately apparent.  The stability of a particular region alone 
would not necessarily render a recognition site inaccessible.  Thus, we proposed that the folding 
pathway might play an essential role in regulating initiation factor access.   Specifically, if the 
energetic barriers between conformational states of an RNA are low, then the RNA can easily 
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explore conformations that are outside its native ensemble (73).  These conformations can have a 
reduced number of structural elements and therefore this flexibility can facilitate sequence 
recognition by translational machinery.   
 The results presented here support this model. Substitution of 166C to 166T at rs4633 in 
COMT mRNA increases the number of favorable isoenergetic conformational states for its 
mRNA transcript.  The dynamics of the 166T-carrying allele become entropy driven such that the 
native conformation becomes less populated as the RNA explores conformations at higher 
energies.  Consequently there are large fluctuations in the positions of each nucleotide and 
thereby enhancing its flexibility.  Further exploration of this model by studying the dynamics for 
a wide variety of RNA structures would be required to prove its fundamental significance. 
 
Implications for cellular expression levels 
Our current results in several transfected mammalian cell lines re-enforce the conclusion 
from our previous studies (15) that the in vivo expression of COMT is strongly dictated by RNA 
structures formed by SNPs rs4818 and rs4680 (Fig. 4.4) yielding the lowest expression levels for 
haplotype HPS.  However, the in vitro translation rate seems to be independent from rs4818 and 
rs4680 interactions and driven solely by local structures near the start codon that is dependent on 
allelic variants of rs4633 (Fig. 4.1B). Furthermore, in two out of four cell lines we also observed 
that the APS haplotype produced the highest protein level, consistent with in vitro translation 
results that are rs4633-dependent.  Thus we observed differential input of three SNPs into two 
distinct structural mechanisms, apparently contributing to translation regulation at different 
levels.   
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 These results are in line with the observed mRNA structure-dependent differences in 
efficiency and rate of translation in vivo and in vitro reported previously (44). Since the rate of 
translation is much slower than the rate of RNA folding, it is thought that RNA begins to fold 
locally during the translation process and that the final structure oftentimes is the metastable 
product of local folding.  Thus, the upstream structures dominate folding outcomes in vitro, 
suggesting that folding occurs sequentially. However, when studied in vivo, upstream and 
downstream structures are presented equally and folding outcomes reflect the relative stability of 
alternative structures, probably facilitated by cellular chaperone proteins associated with nascent 
RNAs (44).   
 The variation in COMT expression levels across different systems could potentially be 
explained by the experimental observation that RNA can adapt specific structures in cells due to 
rapid exchanging of states facilitated by proteins bound to nascent RNAs (44) in contrast to in 
vitro translation conditions.  Because the rate of RNA folding is on the scale of microseconds 
and thus much faster than the rate of transcription, there is a preference for local folds as opposed 
to long-ranged base pairs.  This preference may be diminished in cells by specific RNA-binding 
proteins that allow exchange of secondary structures through branch migration (44).  Our results 
suggest that the contribution of these cellular proteins is tissue specific, such that in some cell 
lines the overall cellular protein expression is almost exclusively controlled by these factors, 
while other cell lines recapitulate the results found in vitro using rabbit reticulocyte lysates (Fig. 
4.4). 
 It is also plausible that in some cell lines, other factors regulating translation are more 
strongly contributing to protein expression.  The abundance of tRNAs with synonymous codons 
are known to vary in the cell up to ten-fold across different human tissues (78).  The availability 
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of tRNAs during translation could also contribute to the relative speed at which the protein is 
synthesized. 
 Alternatively, it is possible that structural modulation of RNA itself is not the sole 
explanation for differences in protein expression, and there may be additional mechanisms 
contributing to translational regulation.  These downstream structural motifs may potentially be 
recognized by external biological factors and subject to further regulation.  For example, the 
Fragile X Mental Retardation Protein (FMRP), an established regulator of translation, is known 
to bind to specific structural RNA motifs (79,80) and can downregulate their expression by 
association with the RNA-induced silencing complex (81,82).  This cascade of structural and 
cellular mechanisms at the mRNA level is likely to be defined by other specific cellular 
components and thus contribute to differences in COMT protein expression levels in a tissue-
dependent manner.   
 From a broader perspective, since the APS haplotype carries a non-synonymous met158 
variation known to create a thermolabile mutant and thus display lower enzymatic activity 
(12,16) in comparison with wild type val158, it is remarkable that its protein expression level can 
be significantly higher than wild type LPS haplotype.  Thus our results represent a potential 
compensatory mechanism of APS haplotypes to overcome lower enzymatic activity via 
overexpression in specific cell lines.  
 
Conclusions 
The results presented here demonstrate a new molecular mechanism thereby synonymous 
substitution of a known functional human COMT haplotype contributes to translation efficiency, 
thus representing an exciting example of evolutionary selection of an RNA-structure 
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destabilizing allele to compensate for a destabilizing amino acid substitution within a mutant 
protein structure.  Importantly, this change did not only affect the stability of RNA structure but 
rather its dynamics, suggesting that increased conformational flexibility enhances translational 
efficiency.  This mechanism by which the destabilizing allele facilitates translation provides a 
new perspective in functional genomics and requires further investigation to determine the extent 
of its fundamental applicability for common genetic variations in human population.  
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Figure 4.1. Haplotypes of COMT and corresponding expression levels.  (A) Organization of 
SNPs for the three haplotypes along COMT gene.  Percent frequency of each haplotype from a 
cohort of 202 healthy Caucasian females is indicated on the right (13).  The LPS designed 
mutant used for later experiments is also included for comparison.  (B) In vitro translation in 
rabbit reticulocyte lysates.  Both LPS and HPS share the same expression levels, while APS 
exhibits higher expression levels.  To test whether this is due to the rs4633 SNP near the start 
codon, we mutated the LPS variant from 166C to 166T.  The resultant LPS-T166 mutant displays 
expression levels on par with APS.   
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Figure 4.2.  Secondary structure analysis of 166C and 166T-allelic variants of COMT by Mfold.  
(A) Free energy profile (ΔG) for target structure opening in the vicinity of the rs4633 SNP and 
the start codon for 166C and 166T-allelic variants determined using OligoWalk.  (B) The most 
probable RNA secondary structural predictions for 166C and 166T-allelic variants near start codon.  
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We zoom in toward the regional differences between the allelic variants.  The start codon is 
colored in green and the varying SNP is colored in red.  The regions of difference are within the 
motifs labeled Loop I, Stem I and Stem II.  The two stems leading to the Loop I and Stem II 
(capped at base pairs 46-110 and 29-178, respectively) are identical as are the rest of the 
nucleotides within the 210 nucleotide window (Supplementary Material, Figs. S1-S3).  Both 
DMD and Mfold predict identical secondary structures for the 166C-allelic variant and 166T-allelic 
variant.  
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Figure 4.3. Tertiary structure analysis by DMD simulations indicate that the unfolding energy 
barrier is lower for 166T allele thus enhancing its conformational flexibility to explore higher 
energy states. (A and B) Structures of variants as predicted using DMD.  Leftmost structures 
represent the native tertiary structure for each allelic variant.  The middle structures are the 
secondary structural elements as predicted by DMD.  The rightmost structures are represented in 
sausage format where thicker backbones represent larger root mean squared fluctuations within 
the native ensemble (see Materials and Methods).  Regions of the RNA are color-coded to 
correspond to different motifs: Loop I (blue), Stem I (green), and Stem II (red).  (A) Structures of 
166C-allelic variant. (B) Structures of 166T-allelic variant. (C) The folding transition temperature 
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for 166T is lower than 166C, as denoted by the peak in specific heat of folding.  Specific heats 
were determined using weighted histogram analysis method.  The vertical droplines represent the 
standard deviation for each plot point.  (D) Histogram of free energies derived from replica-
exchange simulations.  The native ensembles that correspond to the structural motifs as predicted 
by Mfold are denoted on the plot.  (E and F) Maps illustrating frequency of contacts at a 
temperature of 0.10 ε/kB. (E) Frequency of contacts for 166C-allelic variant.  The most frequent 
contacts shown are representative of the native state alone, where the first lower left diagonal 
line is representative of Stem I (nucleotides 5 through 32 of the simulation correspond to 
nucleotides 124 through 151 on the transcript).  The second smaller diagonal line on the upper 
right of the plot represents the contacts formed from the Stem II (nucleotides 34 through 51).  (F) 
Frequency of contacts for 166T-allelic variant.  Even at the lowest simulation temperature, the 
166T SNP creates an ensemble of states where many different enthalpic contacts are made 
throughout its folding simulation but are entropically unfavorable.   
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Figure 4.4.  Protein expression levels of COMT constructs that code for three COMT haplotypes 
in the range of mammalian cell lines.  The constructs were transiently transfected into indicated 
cell lines and its protein expression were analyzed via Western blotting. Top band: β-actin.  
Lower band: COMT.  Cell lines: COS-1 monkey kidney cells, HEK-293 human embryonic 
kidney cells, HepG2 human liver cells, and MCF-7 human breast cells.  Among these cell lines, 
APS protein expression is equivalent or higher than LPS, while HPS exhibits significantly lower 
levels compared to the two haplotypes.  
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Figure 4.S1.  Mfold-predicted structure of LPS from nucleotides 1-210. 
Regions different between three haplotypes reside in nucleotides 119-171. 
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Figure 4.S2.  Mfold-predicted structure of APS from nucleotides 1-210. 
Regions different between three haplotypes reside in nucleotides 119-171. 
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Figure 4.S3.  Mfold-predicted structure of HPS from nucleotides 1-210. Regions different 
between three haplotypes reside in nucleotides 119-171. 
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Figure 4.S4.  Suboptimal RNA secondary structural prediction for 166C allelic variant near start 
codon.  The structures depicted here are from nucleotides 119 to 171 only focusing regional 
differences between the allelic variants.  Green brackets denote locations of the start codon.  Red 
arrows denote the SNP specific to this allelic variant.  (A) Optimal structure.  (B) Suboptimal 
structure. Only one suboptimal structure for C allelic variant was predicted when percent 
suboptimality is set to 30 (when only folding within 30% from the minimum free energy will be 
computed). 
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Figure 4.S5.  Suboptimal RNA secondary structural predictions for 166T allelic variant near start 
codon.  The structures depicted here are from nucleotides 119 to 171 only focusing regional 
differences between the allelic variants. Green brackets denote locations of the start codon.  Red 
arrows denote the SNP specific to this allelic variant.  (A) Optimal structure.  (B-D) Suboptimal 
structures. All suboptimal structures for T allelic variant are predicted when percent 
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suboptimality is set to 30 (when only folding within 30% from the minimum free energy will be 
computed).  
 
 
Table 4.S1.  Comparison of root mean square fluctuations (RMSF) at each nucleotide for both 
allelic variants.  Values here are used to generate the sausage diagrams as depicted in Fig. 3 of 
the main text. 
 
Nucleotide # 166C Variant RMSF 166T Variant RMSF 
1 2.20 9.58 
2 2.20 9.58 
3 1.44 9.77 
4 3.21 7.70 
5 1.04 7.64 
6 1.45 6.64 
7 1.95 5.84 
8 2.99 6.24 
9 1.97 6.77 
10 3.24 1.54 
11 4.13 3.65 
12 2.95 4.73 
13 4.57 1.64 
14 4.88 4.31 
15 3.84 3.35 
16 5.48 4.65 
17 4.64 7.31 
18 4.33 5.51 
19 4.68 8.32 
20 3.93 10.37 
21 3.93 8.92 
22 3.80 11.09 
23 3.97 11.11 
24 3.69 8.92 
25 3.77 11.16 
26 4.40 9.24 
27 4.28 6.84 
28 3.96 8.77 
29 4.41 4.75 
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30 3.90 5.74 
31 3.91 3.10 
32 3.81 5.63 
33 3.32 2.23 
34 3.22 7.48 
35 3.13 7.53 
36 2.84 4.55 
37 2.78 8.99 
38 2.79 8.13 
39 2.28 4.67 
40 2.80 9.39 
41 2.91 8.01 
42 2.31 5.96 
43 3.43 8.92 
44 3.66 6.91 
45 3.04 3.59 
46 4.40 7.43 
47 4.60 3.59 
48 3.80 0.51 
49 5.43 3.88 
50 5.40 4.06 
51 4.34 3.12 
52 6.32 1.86 
53 5.78 2.90 
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 ABSTRACT: Peripherally injected serotonin has shown to produce a hyperalgesic 
effect.  Thus far, the 5-HT1A receptor is the major target consistently associated with this 
response. Here we show that serotonin inhibits catechol O-methyltransferase (COMT), another 
protein involved in the pain response pathway, via non-competitive inhibition with catechol 
substrates (Ki = 44 µM).  From computational modeling, serotonin actively competes with the 
methyl donor S-adenosyl-L-methionine (SAM) within the active site.  Binding of COMT to 
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serotonin inhibits the methyl donor from entering the active site, thus preventing methylation of 
COMT substrates.  Animal model studies using mice show that serotonin-induced hyperalgesia 
is reduced when SAM is co-administered.  Our results suggest that inhibition of COMT via 
serotonin binding contributes to hyperalgesia, and blocking this interaction with SAM may 
provide another strategy to potentiate analgesic efficacy of serotonin; for example, by selective 
serotonin reuptake inhibitor treatments.   
 
 
INTRODUCTION 
 Anti-nociception associated with serotonin (5-hydroxytryptamine, or 5-HT) has been a 
continued area of study for the past several decades (83,84).  Drugs known to act on 5-HT 
receptors have been shown to lower the response to noxious stimuli when administered (85). 
Serotonin concentration is regulated in patients by prescribing selective serotonin reuptake 
inhibitors (SSRIs) (86).  This class of compounds acts to increase the extracellular concentration 
of serotonin by preventing the presynaptic cell from its reuptake and therefore allowing the 
postsynaptic receptors to continue with serotonin binding.  Most commonly, serotonin 
concentrations are regulated in patients to treat for disorders such as depression and anxiety.  
SSRIs are part of a much larger family of anti-depressant compounds. 
 Anti-depressants are also used in the clinic to treat chronic pain conditions, such as 
fibromyalgia and rheumatoid arthritis (86).  However, the mechanisms responsible for these 
analgesic effects are poorly understood (87).  It is known that anti-depressants can differ in their 
analgesic efficacy (87).  SSRIs exhibit lower analgesic properties in comparison to other anti-
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depressants.  Similarly, injecting serotonin peripherally to the brain is less efficacious as opposed 
to increasing serotonin concentration indirectly by administering SSRIs (88).   
 Furthermore, analgesia is not an exclusive property of serotonin.  Serotonin is also known 
to produce a hyperalgesic response when injected peripherally to other tissues (89).  A specific 
class of 5-HT receptors (5-HT1A) is believed to be responsible for creating a hyperalgesic 
response; however, the extent it contributes is unknown.  The perception of pain is a complex 
response in which several classes of proteins are involved, and the extent that they are implicated 
is dependent upon the received noxious stimulus.   
 Catechol O-methyltransferase (COMT) is an enzyme that has been implicated in the 
perception of mechanical, thermal, ischemic, and inflammatory pain in both humans and rodents 
(13,17,90).  Its association with broad range of noxious stimuli suggests its critical role as an 
underlying factor for the fundamental processes of pain perception.  The enzymatic activity of 
COMT is correlated with the sense of perceived pain; higher levels of COMT activity correspond 
to lower pain sensitivity (13,15,17,90).  Thus, compounds or cellular regulatory factors that 
lower COMT activity can enhance the pain sensation in individuals.   
 A co-factor necessary for methylation of COMT substrates is S-adenosyl-L-methionine 
(SAM).  Comparing the chemical structures of SAMs and serotonin, we see that the indole ring 
of serotonin is similar to the adenosine motif of SAM.  Thus, we hypothesize that serotonin may 
play a role as a competitive inhibitor of SAMe and thus provide an avenue for COMT-dependent 
pathway in serotonin-induced hyperalgesia.  Specifically, the inhibition of COMT activity 
through serotonin would reduce the ability of COMT to methylate its native catecholamine 
substrates, including several neurotransmitters, such as dopamine, epinephrine, and 
norepinephrine (1).  Preventing methylation of epinephrine and norepinephrine will lead to 
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continuous activation of a pain signaling through the β2 – and β3–adrenergic receptor 
pathways(17).  Here, we investigate the binding between serotonin and COMT using a 
combination of in silico, in vitro, and animal model studies. 
 
 
MATERIALS AND METHODS 
Docking Simulations of Serotonin to COMT Active Site 
 We employ the MedusaDock package to generate possible ligand conformations within 
the protein active site, and utilize the MedusaScore package to evaluate each conformation 
generated by MedusaDock (26,27). MedusaDock enables flexible docking of both the ligand and 
the side-chain amino acids of the protein.  We perform all ligand docking simulations using the 
crystal structure of human COMT (PDB: 3BWM) (9).    
 Prior to all docking simulations, we first stripped all crystallized ligands bound to 
COMT.  Crystallographic waters that were in the active site were retained for our docking 
simulations.   We performed 200 docking simulations for serotonin, where each simulation 
began with a different seed number and each conformation generated from a simulation was 
subsequently minimized.  All conformations were then ranked according to their free energy 
value.  The lowest energy structure is determined to be the native pose.   
 
Binding Measurements using Surface Plasmon Resonance 
 Purified COMT protein (derived from porcine liver) and serotonin ligand was obtained 
from Sigma-Aldrich.  Protein concentration was verified by performing a BCA assay (Thermo 
Scientific).  Purified COMT was biotinylated at its surface lysine residues using EZ-Link NHS-
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LC-LC Biotin (Thermo Scientific) at a 1:1 mole ratio of biotinylating reagent to protein and 
subsequently purified using a 1 mL Sephadex G-25 medium spin column.  Biotinylated COMT 
was kept in a buffer (10 mM Tris (pH 7.4), 1 mM MgCl2, and 1 µM DTT) and stored at 4 °C 
until use.   
 Surface plasmon resonance (SPR) measurements were conducted at 25 °C using a 
Biacore 2000 instrument with a previously established protocol (91).  Biotinylated COMT was 
first attached to a streptavidin-coated flow cell (sensor chip SA or Biotin CAPture Kit, GE 
Healthcare), followed by a buffer flow, introduction of serotonin-containing buffer, and then a 
final wash with buffer.  Here the flow rate was established at 5 µL/min. 
 The dissociation rate of the serotonin-COMT complex was determined by fitting the 
dissociation data to a single-exponential decay.   
 
Here, the response unit from the SPR machine is denoted as R.  Once the dissociation rate is 
determined, the association rate of serotonin to COMT can be found by fitting to the following 
equation: 
 
 
Radiolabeled SAM Activity Assay 
 Activity of COMT was measured through a series of experiments where the enzyme was 
incubated with the substrate catechol (dissolved in H2O, Fisher Scientific) and S-[methyl-3H]-
adenosyl-L-methionine (PerkinElmer, 10.0 Ci/mmol) (92).  Reactions were carried out in a 
buffer containing 10 mM Tris (pH 7.4), 1 mM MgCl2, and 1 µM DTT with a total reaction 
volume of 100 µL.  
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 To determine the linear range of the activity assay, SAM concentration (1 µM) was held 
constant while COMT concentration was varied (10 – 80 ng/µL).  Each reaction was placed in a 
clean PCR tube and incubated at 37 °C for 30 minutes.  After incubation, reactions were 
terminated by addition of 100 µL of 1M HCl to each tube.  Radiolabeled catechol products were 
extracted from the reaction by adding 10 mL of scintillation fluid (MonoFlow I, National 
Diagnostics) and quantified using a scintillation counter.  Activities were normalized for each 
reaction by performing a duplicate reaction with the COMT inhibitor, OR-486 (0.5 mg of 
inhibitor dissolved in 30 µL DMSO and 20 µL of 0.9% saline; OR-486 buffer alone does not 
inhibit reaction), and subtracting its radioactivity.  We found that the linear range was between 
10 and 40 ng/µL, and thus for all subsequent experiments we used a COMT concentration of 20 
ng/µL.   
 Kinetic experiments were performed at a variety of catechol concentrations (0, 0.5, 1, 3.3, 
5, 10, and 33 µM) while maintaining constant SAM (1 µM) and COMT (20 ng/µL) 
concentrations.  Reactions were set-up for a variety of time points: 0, 5, 10, 30, 60, and 120 
minutes.  Each time-point reaction is incubated at 37 °C and then quenched with 1M HCl at its 
specified time point.  Products were quantified as discussed above.  Serotonin-inhibition 
experiments were conducted for the same catechol concentrations, but with the addition of 100 
µM of serotonin (Sigma) to each reaction.   
 Kinetic parameters were determined by first fitting the data sets to a single-site 
Michaelis-Menten model (for reference), followed by a two-site Michaelis-Menten model as 
given by (12):  
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where catechol is abbreviated as “Cat.”  To determine the mechanism of serotonin-inhibition, we 
calculated the apparent Ki (Ki,app) of inhibition for both a competitive and non-competitive 
inhibitor, and compared which Ki,app yielded the lowest value.  The apparent Ki for a competitive 
inhibitor is given by 
 
 
where Km,app is the apparent Km,Cat for the serotonin-inhibited curve.  The apparent Ki for a 
noncompetitive inhibitor is given by 
 
 
where Vmax,app is the apparent Vmax for the serotonin-inhibited curve.   
 
 
von Frey Experiments with Mice 
 For the automated von Frey tests, mice were placed in individual transparent Plexiglas 
cubicles set atop a perforated metal floor (with 5-mm diameter holes 7 mm apart), and separated 
from each other by opaque dividers. The automated von Frey fiber (Ugo Basile Dynamic Plantar 
Aesthesiometer) was applied to the mid-plantar hind paw. Prior to testing, the mice were 
habituated to their surroundings for one hour. Three separate threshold determinations were 
taken at baseline and then averaged. Following the injections, one threshold determination was 
made on each hind paw at every time point.  
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RESULTS AND DISCUSSION 
Serotonin Binds to COMT 
 Binding interactions between COMT and serotonin were verified through surface 
plasmon resonance (Figure 5.1).   From the data, both the rate of association (kon) and 
dissociation (koff) can be determined.  We find that serotonin dissociates from COMT with a koff 
rate of 0.0012 s-1, and binds to COMT with a kon rate of 13.7404 M-1s-1.  The equilibrium 
dissociation constant (KD) was determined by dividing the dissociation rate from the association 
rate, and calculated to be 87 µM.  A calculated 87 µM KD for serotonin is a reasonable binding 
affinity when comparing to previously reported values for COMT ligands (12).  The lowest 
reported KD affinity reported among COMT ligands was for SAM, with a KD of 20.2 µM.  In 
contrast, many common COMT substrates exhibited dissociation constants in the range of 40 – 
400 µM.  The higher dissociation constants observed for COMT substrates is most likely a 
consequence of its low substrate specificity.  The binding site for catechol is quite solvent 
accessible and thus can accommodate many ligands (9).  Although COMT will not methylate 
most phenols or gallols (2), virtually any catechol is susceptible for methylation including 
bulkier steroid compounds.  Thus, with a KD among the same order of magnitude in comparison 
to existing substrates, the interaction between serotonin and COMT could be viable within the 
cell. 
 
Computational Docking of Serotonin to COMT 
 Next we investigated how serotonin would be accommodated within the active site of 
COMT.  Using computational docking tools, we dock serotonin to an apo-COMT protein to 
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predict its native pose in the active site.  We find that serotonin occupies a site in the pocket that 
sterically overlaps with the binding site of SAM (Figure 5.2A).  In the crystal structure of holo-
COMT, His142 participates in an edge-to-face interaction with the adenosine of SAM (9).  
However, during serotonin binding, His142 donates a hydrogen bond with the amine sidechain 
of serotonin (Figure 5.2B).  Another hydrogen bonding interaction takes place with the serotonin 
amine and the sidechain carboxyl group of Asp90.  These two residues are responsible for 
positioning serotonin near the binding pocket of SAM, thereby preventing SAM from accessing 
its site.  The carbonyl backbone of His142 also accepts a hydrogen bond from the hydroxyl 
group of serotonin. 
 Two more residues form hydrogen-bonding interactions with serotonin.  The carbonyl of 
Met40 forms a hydrogen bond with the imidazole group of serotonin, while Lys144 forms a 
hydrogen bond with the hydroxyl group of serotonin.  The sidechain of Met40 also packs against 
the indole ring of serotonin.  Overall, the results of this docking simulation suggest that serotonin 
may inhibit COMT activity by preventing the cofactor SAM from binding. 
 
Serotonin Inhibition of COMT Activity 
 To test whether the binding of serotonin leads to inhibition of COMT activity, we 
performed a set of kinetics experiments to measure the differences of reaction rates both in the 
presence and absence of serotonin (Figure 5.3A,B).    We measured the variance in reaction 
velocity with respect to changes in catechol concentration.  A double-reciprocal plot comparing 
COMT velocities in the presence and absence of serotonin shows that addition of 100 µM of 
serotonin decreases the reaction velocity of COMT (Figure 5.3C).  Thus, serotonin binds COMT 
to inhibit its activity, rather than activate COMT.  These results are in line with our 
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computational model, since serotonin occupies a region within the active site that may be 
hindering SAM binding.  Furthermore, serotonin does not possess a methyl group to donate 
which would have compensated for the lack of SAM binding.   
 We determined the mechanism by which serotonin inhibits COMT by fitting our data to a 
two-site Michaelis-Menten model (see Materials and Methods; Figure 5.3D).  The Michaelis-
Menten equilibrium constant for catechol binding was determined for both in the absence of 
serotonin (KM) and in the presence of 100 µM serotonin (KM,app).  A comparison of KM (16 µM) 
and KM,app (18.5 µM) shows a negligible difference between their affinities toward catechol.  
However, a comparison of the maximum velocity rates reveals a greater difference.  The Vmax in 
the absence of serotonin was 16 nM/min while the apparent Vmax,app in the presence of serotonin 
was 7 nM/min.  Our data suggests that serotonin is a non-competitive inhibitor with respect to 
catechol, since the inhibitory effect is found in the maximum reaction rate as opposed to the 
binding affinity for catechol.  This mechanism is in line with our structural model, since the site 
for serotonin binding is located near the SAM binding site, and would still allow for catechol 
binding from a steric viewpoint. 
 Given the differences between Vmax and Vmax,app, we can calculate the inhibition constant 
for serotonin (Ki,app).  We find that Ki,app is 44 µM, which is within the vicinity of our 
approximate KD determined via SPR (~50 µM).  Overall, our results show that serotonin binds to 
COMT and inhibits its activity at a concentration that is similar to natural COMT substrates.   
 
Serotonin-Induced Hyperalgesia Rescued by Addition of SAM in Mice 
 Our in vitro results and in silico models suggest that serotonin is an inhibitor COMT.  
However, whether this inhibition substantially contributes to the observed serotonin-induced 
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hyperalgesia cannot be determined from this data alone.  Our structural model suggests that 
serotonin inhibits COMT activity by actively competing with SAM at the active site.  This 
mechanism is further supported by our kinetics studies.  Thus, by increasing the concentration of 
SAM we can lower the probability of serotonin occupying the active site of COMT.   
 If serotonin inhibition of COMT through competitive inhibition with SAM contributes to 
hyperalgesia, we would expect that administration of SAM would lower the observed 
hyperalgesia induced by serotonin.  We tested this hypothesis by performing several withdrawal 
threshold experiments with intraplantar administration of serotonin to mice (93).   
 Mice were fed a diet that included 10mg/kg of SAM per day for a total of 10 days.  
Repetition of the withdrawal threshold assay with this set of mice (n = 4) showed a reduced 
hyperalgesic response to serotonin.    The results of our mouse models indicate that serotonin-
induced hyperalgesia is a response that is associated with COMT inhibition.  Furthermore, our 
administration of SAM indicates that serotonin is indeed actively competing with SAM for the 
active site of COMT.   
 
Implications for Serotonin-Induced Hyperalgesia and SSRIs 
 Our current results, consistent with a line of previously published observation(93), show 
that there is a reproducible effect of hyperalgesia associated with serotonin.  Yet, increasing the 
concentration of serotonin is also commonly used as an analgesic strategy for clinical treatment 
of chronic pain conditions (86,94).  Selective serotonin reuptake inhibitors (SSRIs) act to 
increase the concentration of serotonin by inhibiting its reuptake by the presynaptic, and are 
administered for conditions such as fibromyalgia, rheumatoid arthritis, and migraines (86).  
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However, SSRIs are most commonly prescribed as an anti-depressant.  Hence, there is a clear 
dichotomy in serotonin contribution to pain states.   
 The pain response can be attributed to many factors, including nociception and 
apperception.  Anti-depressants are commonly prescribed to aid chronic pain patients as an 
analgesic, although their mechanisms of action are not fully understood (87). The analgesic 
effects of SSRIs are very modest.  A possible explanation for their diminished efficacy may be 
due to a simultaneous hyperalgesic effect caused by the increase in serotonin concentration and, 
based on our results, this hyperalgesic effect can be at least in part attributed to serotonin-
dependent COMT inhibition.  Thus, our results open up a new avenue for increasing the 
analgesic efficacy of SSRIs by co-administrating with SAM.   
 
CONCLUSIONS 
 The hyperalgesic effect associated with serotonin is likely a response attributed to a 
variety of proteins.  While the 5-HT1A receptor has been known to produce nociceptive effects, 
we have shown that COMT is another protein that can cause a hyperalgesic response in the 
presence of serotonin.  The mechanism behind COMT-inhibited hyperalgesia is likely due to the 
competition between SAM and serotonin for the active site.  By further understanding the 
mechanisms behind serotonin-induced hyperalgesia, co-administrating the appropriate inhibitors 
or cofactors could increase its analgesic efficacy.   
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Figure 5.1. Serotonin binds to COMT.  SPR data is fitted to association and dissociation curves 
to determine the kinetics of serotonin binding (kon = 0.0012 s-1, koff = 13.7404 M-1s-1).  
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Figure 5.2. Structural model of serotonin within COMT active site.  (A) Surface representation 
of serotonin binding to a pocket within COMT.  Serotonin structure is shown in cyan; SAM 
structure is shown in green.  The overlapped structures indicate that the amine sidechain of 
serotonin prevents SAM from actually binding to COMT.  On the COMT surface, blue 
represents positively-charged, red represents negatively-charged, and white represents neutrally-
charged regions.  (B) Interactions of serotonin with residues inside COMT active site.  COMT 
structure and residues are shown in green; serotonin is shown in blue.  Hydrogen-bonding 
interactions are highlighted with yellow-dashed lines.   
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Figure 5.3. Inhibition of COMT with serotonin.  (A) and (B) show the reaction rates of COMT 
at different catechol concentrations in the absence and presence of 100 µM serotonin, 
respectively.  (C) Lineweaver-Burk plot comparing the reciprocal velocities of activity against 
the reciprocal concentration of catechol in the absence (black) and presence (red) of 100 µM 
serotonin.  The higher slope observed for serotonin indicates some level of inhibition.  (D) 
Michaelis-Menten determination of equilibrium inhibition constant.  Activity assays in the 
absence (black) and presence (red) of 100 µM serotonin were fit to a two-site Michaelis-Menten 
model.  While the KM for catechol remains relatively the same, the Vmax shows some noticeable 
differences thereby suggesting a non-competitive mechanism of inhibition between serotonin and 
catechol. 
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Figure 5.4. Mouse models of serotonin-induced hyperalgesia.  (A) and (B) Serotonin was 
injected into the ipsilateral and contralateral paw, respectively.  We find that the withdrawal 
threshold for the paws with serotonin (red) injected were statistically smaller compared to those 
with saline (black).  (C) Demonstration that increasing SAM concentration lowers serotonin-
induced hyperalgesia.  Mice with a diet including 10 mg/kg of SAM per day  (red) showed a 
higher withdrawal threshold when administered serotonin compared to mice without a regular 
diet of SAM (black).   
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CHAPTER VI: CONCLUDING REMARKS 
 
 We have discussed several structural features of COMT that leads to further 
understanding of its enzymatic activity.  Crystal structures of COMT have confirmed a kinetic 
mechanism of how its ligands are accommodated within its active site: i.e., SAM is initially 
bound, followed by a divalent metal cation and then the substrate.  Previous biochemical data 
confirmed that a metal is necessary for catalysis; here, we proposed a mechanism that the metal 
is necessary not only for coordination of the catechol, but to correctly align the sulfonium group 
as well.  Our docking studies discussed here leads to a further understanding of the fundamental 
mechanism by which COMT conducts catalysis. 
 Regioselectivity has been an overlooked feature of COMT until now.  It is interesting to 
note that this feature has been evolutionarily conserved throughout nature.  Our quantum 
calculations produce reaction barrier height differences between the two possible methylation 
positions of each catechol, revealing that the regioselectivity of COMT enhances its catalytic 
rate.  To our knowledge, this is the first example of regioselectivity as a means of catalytic 
enhancement as opposed to chemical specificity.  Thus, our finding here not only broadens our 
knowledge of how COMT lowers the barrier for its methylation reaction, but also proposes a 
potentially significant alternative role for regioselection in other enzymes.   
 The functionality of COMT is not limited to its structural features, but also how it is 
regulated within the cell.  Metabolites within the celluar cytoplasm are often able to affect the 
functionality of various enzymes via means such as allosteric activation or direct inhibition.  
Here, we have discussed an example of COMT regulation through serotonin inhibition.  
Serotonin is a monoamine neurotransmitter that is synthesized from the amino acid tryptophan 
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within the body.   The presence of serotonin is known to produce both algesic and analgesic 
effects.  We find that a reason why SSRIs may have such modest analgesic effects compared to 
other anti-depressants is due to its inhibition of COMT.    Specifically, we observed that 
serotonin is inhibiting COMT activity by competing with the methyl donor SAM for the active 
site.  Thus, a clinically relevant solution to increase SSRI analgesia is to co-administrate with 
SAM, as we observed for our mouse models.   
 The regulation of COMT protein expression is another method for the cell to manage 
COMT enzymatic activity.  We find that COMT protein expression is regulated in some cell 
lines via the translational efficiency of its mRNA.  Specifically, we observed that the APS 
haplotype that encodes for a mutant isoform of COMT (Val108Met) contains a SNP within the 5’ 
end of its mRNA that enables higher translational efficiency compared to the other haplotypes.  
Our secondary and tertiary structural analysis of COMT mRNA for each haplotype shows that 
the dynamics at the 5’ end vary depending on the SNP present.  The C→T mutation found at 
position 166 of the mRNA strand coding for APS creates a highly flexible and partially folded 
region that facilitates translation for the ribosome. Our work on COMT mRNA regulation 
contains two main conclusions.  First, the allelic variant responsible for increased translation 
efficiency is located exclusively on the haplotype coding for the low activity protein, suggesting 
evolutionary selection of an RNA-structure destabilizing allele to compensate for the low activity 
mutation present within its protein structure.  Second, previous works have shown only a 
correlation between the free energy of the 5’ end of a RNA transcript and protein expression.  
Here we provide a mechanism whereby destabilizing alleles may facilitate translation initiation.  
These findings have broad biological implications and suggest potential applicability for other 
common genetic variations in the human population. 
 94	  
 Our structural studies of COMT have led insight into both its enzymatic activity and 
potential mechanisms of regulation.  Furthermore, by exploring the properties of COMT we have 
uncovered additional methods by which other enzymes may function.  For example, 
regioselection may be a property that other enzymes possess to lower the activation barrier for 
their respective catalyzed reactions.  Likewise, genes may evolve to increase its protein 
expression by selecting for nucleotides that disable its ability to form structurally stable mRNA 
structures.  These mechanisms provide a blueprint toward identifying additional modes of 
activity and regulation for other enzymes. 
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